0001533357 --04-30 Yes false A draft of the Company 10-K was incorrectly filed on August 15, 2023 without approval. It should not be relied on as the audited financials of the Company. The amended copy being filed herein accurately reflects the Company's financial conditions as of April 30, 2023. true 2023 FY 0001533357 2022-05-01 2023-04-30 0001533357 2023-04-30 0001533357 2022-10-31 0001533357 2023-08-25 0001533357 2023-04-30 2023-04-30 0001533357 2022-04-30 2022-04-30 0001533357 2022-04-30 0001533357 us-gaap:SeriesAPreferredStockMember 2023-04-30 0001533357 us-gaap:SeriesAPreferredStockMember 2022-04-30 0001533357 us-gaap:SeriesBPreferredStockMember 2022-04-30 0001533357 us-gaap:SeriesBPreferredStockMember 2023-04-30 0001533357 2021-05-01 2022-04-30 0001533357 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2023-04-30 0001533357 us-gaap:PreferredStockMember 2022-05-01 2023-04-30 0001533357 us-gaap:CommonStockMember 2022-05-01 2023-04-30 0001533357 2021-04-30 0001533357 us-gaap:PreferredStockMember 2021-04-30 0001533357 us-gaap:CommonStockMember 2021-04-30 0001533357 us-gaap:PreferredStockMember 2021-05-01 2022-04-30 0001533357 us-gaap:CommonStockMember 2021-05-01 2022-04-30 0001533357 us-gaap:PreferredStockMember 2022-04-30 0001533357 us-gaap:CommonStockMember 2022-04-30 0001533357 us-gaap:PreferredStockMember 2023-04-30 0001533357 us-gaap:CommonStockMember 2023-04-30 0001533357 2008-06-19 2023-04-30 0001533357 us-gaap:FairValueInputsLevel1Member 2022-04-30 0001533357 us-gaap:FairValueInputsLevel2Member 2022-04-30 0001533357 us-gaap:FairValueInputsLevel3Member 2022-04-30 0001533357 us-gaap:FairValueInputsLevel1Member 2023-04-30 0001533357 us-gaap:FairValueInputsLevel2Member 2023-04-30 0001533357 us-gaap:FairValueInputsLevel3Member 2023-04-30 0001533357 fil:InitialLicenseFeeMember 2023-04-30 0001533357 fil:LicenseAgreementMember 2023-04-30 0001533357 fil:March2018NotePayableMember 2022-04-30 0001533357 fil:July62018NotePayableMember 2022-04-30 0001533357 us-gaap:PreferredStockMember 2023-02-01 2023-04-30 0001533357 fil:July182018NotePayableMember 2022-04-30 0001533357 fil:July182018NotePayableMember 2023-04-30 0001533357 fil:ConvertibleNotePayable1Member 2023-04-30 0001533357 fil:ConvertibleNotePayable1Member 2022-05-01 2023-04-30 0001533357 fil:ConvertibleNotePayable6Member 2023-04-30 0001533357 fil:ConvertibleNotePayable7Member 2023-04-30 0001533357 fil:ConvertibleNotePayable14Member 2023-04-30 0001533357 fil:ConvertibleNotePayable26Member 2023-04-30 0001533357 fil:DerivativeLiabilityMember 2021-04-30 0001533357 fil:DerivativeLiabilityMember 2021-05-01 2022-04-30 0001533357 fil:DerivativeLiabilityMember 2022-04-30 0001533357 fil:DerivativeLiabilityMember 2022-05-01 2023-04-30 0001533357 fil:DerivativeLiabilityMember 2023-04-30 0001533357 fil:CommonStockIssuance8Member 2019-05-20 2019-05-20 0001533357 fil:PreferredStockIssuance1Member 2019-05-20 2019-05-20 0001533357 fil:PreferredStockIssuance3Member 2021-05-01 2022-04-30 0001533357 fil:PreferredStockIssuance4Member 2021-05-01 2022-04-30 0001533357 2023-04-09 0001533357 fil:PreferredStockIssuance5Member 2022-05-01 2023-04-30 0001533357 us-gaap:SeriesDPreferredStockMember 2023-04-30 0001533357 fil:CommonStockIssuance1Member 2021-05-01 2022-04-30 0001533357 fil:CommonStockIssuance2Member 2021-05-01 2022-04-30 0001533357 fil:CommonStockIssuance3Member 2022-05-01 2023-04-30 0001533357 fil:CommonStockIssuance4Member 2022-05-01 2023-04-30 0001533357 fil:CommonStockIssuance5Member 2022-05-01 2023-04-30 0001533357 fil:StockOptionsMember 2022-05-01 2023-04-30 0001533357 fil:StockOptionsMember 2021-04-30 0001533357 fil:StockOptionsMember 2021-05-01 2022-04-30 0001533357 fil:StockOptionsMember 2022-04-30 0001533357 fil:StockOptionsMember 2023-04-30 0001533357 fil:EmacHandelsAgMember 2022-05-01 2023-04-30 0001533357 fil:MerrillWMosesMember 2023-04-30 0001533357 fil:CharlesCHooperMember 2022-05-01 2023-04-30 0001533357 fil:RabInvestmentsMember 2022-05-01 2023-04-30 0001533357 fil:MerrillWMosesMember 2022-05-01 2023-04-30 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

Amendment-1

(Mark One)

   Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 

 

For the Fiscal Year Ended April 30, 2023

 

   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

 

For the transition period from _______________ to _______________

 

Commission File Number:   000-54851

 

DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

 

          Delaware          

                        99-0363802                      

(State of Incorporation)

(I.R.S. Employer Identification Number)

 

2683 Via De La Valle, Suite G418, Del Mar CA 92014

(Address of principal executive offices)   (Zip Code)

 

Registrant's telephone number, including area code:   (800) 520-9485

Securities registered pursuant to Section 12(b) of the Act:

None

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.0001 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes [   ]   No [ X ]

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes [   ]   No [ X ]

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [ X ]   No [   ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.

Yes [ X ]   No [   ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer

[   ]

Accelerated filer

[   ]

Non-accelerated filer

[X]

Smaller reporting company

 

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


1


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   No [ X ]

 

The number of shares outstanding of the Company’s $0.0001 Par Value Common Stock as of August 25, 2023 was 2,488,678.  The number of preferred shares outstanding was 4,839,616.  The aggregate number of shares of the voting stock held by non-affiliates on October 31, 2022 was 588,086 with a market value of $194,068. For the purposes of the foregoing calculation only, all directors and executive officers of the registrant have been deemed affiliates.   

 

DOCUMENTS INCORPORATED BY REFERENCE

A description of "Documents Incorporated by Reference" is contained in Part IV, Item 15.

 

 

 

 

Amendment -1

 

A draft of the Company 10-K was incorrectly filed on August 15, 2023 without approval. It should not be relied on as the audited financials of the Company. The amended copy being filed herein accurately reflects the Company’s financial conditions as of April 30, 2023.


2


DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

TABLE OF CONTENTS

 

 

 

Page

PART  I

 

 

 

Item 1.

Business

4

 

 

 

Item 1A.

Risk Factors

6

 

 

 

Item 1B.

Unresolved Staff Comments

6

 

 

 

Item 2.

Properties

7

 

 

 

Item 3.

Legal Proceedings

7

 

 

 

Item 4.

Mine Safety Disclosures

7

 

 

 

PART  II

 

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer  Purchases of Equity Securities

7

 

 

 

Item 6.

Selected Financial Data

9

 

 

 

Item 7.

Management's Discussion and Analysis of Financial Condition and Results  of Operations

9

 

 

 

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

14

 

 

 

Item 8.

Financial Statements and Supplementary Data

14

 

 

 

Item 9.

Changes in and Disagreements with Accountants on Accounting  and Financial Disclosure

14

 

 

 

Item 9A.

Controls and Procedures

14

 

 

 

Item 9B

Other Information

15

 

 

 

PART  III

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

15

 

 

 

Item 11.

Executive Compensation

17

 

 

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related  Stockholder Matters

17

 

 

 

Item 13.

Certain Relationships and Related Transactions and Director Independence

18

 

 

 

Item 14.

Principal Accounting Fees and Services

19

 

 

 

PART  IV

 

 

 

Item 15.

Exhibits, Financial Statement Schedules.

20

 

 

 

Signatures

21

 

As used in this report, unless otherwise indicated, “we”, “us”, “our”, “DTII” and the “Company” refer to Defense Technologies International Corp. 


3


 

PART  I

 

Item 1.Business 

 

Defense Technologies International Corp. (the “Company”) was incorporated in the State of Delaware on May 27, 1998.  Effective June 15, 2016, the Company changed its name from Canyon Gold Corp. to Defense Technologies International Corp. to represent the Company’s expansion goals more fully into the advanced technology sector.

 

Our principal executive office is located at 2683 Via De La Ville Suite G418, Del Mar CA 92014 147, telephone (1-800) 520-9485.  Additional office space is subleased from EMAC at 641 West 3rd Street, North Vancouver BC, Canada.

 

Our website address is http://www.defensetechnologiesintl.com.

 

Development of Scanner Technology Business

 

Defense Technologies International Corp.’s (the “Company”) subsidiary PSSI acquired the world-wide exclusive rights to the Passive Security Scan™ a ‘next generation, walk-through personnel scanning system. The Passive Portal™ a patented product (US Patent: 7408461) is an advanced passive scanning technology for detection and identifying concealed threats to be used for the security of schools and other public venues.

 

Our research shows The Passive Portal™ as the only known Walk-Through Scanner in today’s market that is based on PASSIVE SENSING – ZER0-RATION and is therefore totally harmless to the subject being scanned. All other Walk-Through Scanners in the market are based on ACTIVE SCANNING with radiation and therefore can be harmful over time.

 

PSSI has the exclusive World-Wide license to manufacture and sell the Passive Scanning Technology™. We added a Camera for the detection of Elevated Body Temperatures (EBT), our first products are:

Passive Portal™, Passive Portal™ EBT, Passive EBT Station

 

On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC ("CCS"), representing the inventor of the technology and assets that included a new exclusive Patent License Agreement and Independent Contractor agreement.  Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements.  The term of the License Agreement shall be from October 19, 2016, until the expiration of the last to expire of the licensed issued patents or patents to be issued.

 

The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties at the end of each six-month period at the rate of the greater of 5% of gross sales used or sold, or the minimum royalty payment of $25,000. The Company also agreed to compensate investors that have provided funding for the development of CCS's technology with 5 shares of the Company's common stock.  Additionally, CCS will be entitled to receive 1 shares of the Company's common stock upon completed sales of 1,000 passive scanner units based on the CCS technology. On December 14, 2017, the Company issued 20,000 shares of Series B preferred stock to Controlled Capture Systems, LLC to extend the exclusive rights to the Passive Security Scan to March 15, 2018.

 

On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows:

1.Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter. 

2.All payment will be in US dollars or stock of the Company and or its subsidiary.  The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive.  


4


3.Invoices for parts and materials will be billed separately of the license fees noted above. 

The Company capitalized the costs to acquire the License Agreement, including the $25,000 initial licensing fee and the estimated value of $353,600 of the 5shares of the Company's common stock issued on November 10, 2016, to the CCS investors, which value was based on the closing market price of the Company's common stock on the date of the Definitive Agreement. The Company recorded a current liability of $36,000 for the remaining obligation in its consolidated balance sheet as of April 30, 2019.  Once sales of products based on the CCS technology begin, the Company will amortize the capitalized costs over the estimated life of the license agreement as determined by the legal life of patents issued. To date we have sold 10 units to two distributors. The Company reviewed the valuation of the license agreement and determined to impair the asset of $378,600.

 

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as a wholly owned subsidiary.  The Company merged its wholly owned subsidiary, Long Canyon Gold Resources Corp. ("Long Canyon"), into PSSI, with PSSI the surviving entity.  The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company.  The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities.  With the merger of Long Canyon into PSSI, the Company discontinued its mineral exploration business.  The Company concluded the initial development of the technology and will proceed to put the system through the required Beta Test at a high school near Austin Tx. All sales and marketing activities will be executed through PSSI.

 

The security products licensed from CCS as developed by the Company are designed for personal and collateral protection.  The proposed detection technology is intended to provide passive security scanning units for either walk-through or hand-held use to improve security for schools and other public facilities.  The units use electromagnets and do not emit anything (such as x-rays) through the subject.  The Company, in consultation with CCS, recently completed a prototype with optional “Digital Imaging” which will give the user of the scanner the ability to recall the entire traffic passing through the scanner at any time thereafter.  The prototype scanner unit has successfully passed elaborate lab testing and is ready for deployment and demonstration.

 

Competition

 

We believe we have the only known passive scanner technology based on earth magnetic technology that is Radiation Free and does not cause any harm to the subject passing through the scanner.  Our scanners are PASSIVE SENSING and are therefore uniquely suited for school systems and other public venues.  Our competitors’ technology is ACTIVE SENSING based on X-Ray, microwave or radio signals, all of which are harmful over time.  We believe this provides an advantage for our scanners over those developed by our competition.  

 

Sales and Marketing

 

On November 04, 2020, we engaged the services of Jonathan Silver of Cumulus Media Inc of Atlanta GA to assist DTII in Investors Relations and Marketing of its Passive Portal and EBT Station.

 

Through our National Marketing Director. Mr. Jonathan Silver, we have made contact with schools, synagogues as well as other venue holders that have expressed interest in having the Passive Security Scan Unit presented at the school for demonstration and evaluation.  Furthermore, as funding permits, we plan to install a demonstration unit in every state free of charge via the state’s Governor’s Office. We expect major exposure through this program.

 

Jonathan Silver arranged the installation of Demo-Units of the Passive Portal and the EBT Camera (elevated body temperature) at the Coastal Carolina University, Convey SC; Florence County Sheriff’s Detention Center, Effingham, SC; Myrtle Beach Police Department Detention Center, Myrtle Beach, SC.

 

We have signed three Distributorship Agreements. A distributor will get from 20% to 28.5% discount on Gross Sales but is required to purchase a minimum of 10 units at time of signing for a distributorship.  General referrals will earn a 10% discount.

 


5


With the completion of requisite funding, we expect to place the first units during the fall of 2021 and commence a major marketing campaign at the same time.  We believe that we will start production and sales within the coming three to six months.

 

With the start of initial sales, we believe that we will be able to raise major funding through more conventional sources for our production.

 

Production

 

We acquired the necessary machinery and equipment to manufacture and assemble up to 500 Passive Portals per month at our new Dallas Tx production facility. 

 

To date we have manufactured and assembled 35 Passive Portal Units and ten EBT Stations the first thirteen units which will mainly be used for demonstrations and donations to valuable future customers. 

 

In addition, we have all parts for an additional twenty-five Passive Portals at our plant in Dallas, TX. 

 

We installed three Passive Portals and three EBT Stations in S.C. which are working without any flaws as engineered and required by its technology and as endorsed by the end-users. 

 

Trademarks and Copyrights

 

We acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements.  The term of the License Agreement shall be from October 19, 2016, until the expiration of the last to expire of the licensed issued patents or patents to be issued.  CCS currently owns 3 patents and 2 patents pending related to the technology.

 

Employees

 

We presently have five full and part-time Consultants and do not anticipate adding additional employees until our business operations and financial resources so warrant. The Independent Contractor Agreement between the Company and CCS provides that CCS will provide support for the development of the security technology and products.  The management of our Company is provided through a series of service agreements with our officers and directors and key consultants.  

 

Facilities

 

We presently rent office facilities at 2683 Via De La Ville Suite G418, Del Mar CA 92014 that serve as our principal executive offices. Additional office space is subleased from EMAC at 641 West 3rd Street, North Vancouver BC, Canada.

 

Employee Stock Plan

 

We have not adopted any kind of stock or stock option plan for employees at this time.

 

Industry Segments

 

No information is presented regarding industry segments. We are presently an emerging company seeking business opportunities in one segment, the defense, detection and protection products industry.

 

Item 1A. Risk Factors.

 

The occurrence of an uncontrollable event such as the COVID-19 pandemic may negatively affect our operations. A pandemic typically results in social distancing, travel bans, and quarantine.  This may limit access to our suppliers, management, support staff and professional advisors. As the Company’s operations are primarily virtual and depends on numerous third-party consultants, we cannot measure the impact on our operations or financial condition at this point in time.


6


 

Item 1B. Unresolved Staff Comments.

 

This item is not required for a smaller reporting company.

 

Item 2. Properties. 

 

We do not presently own any property.

 

Item 3.Legal Proceedings. 

 

There are no material pending legal proceedings to which the Company or its subsidiary is a party, or to which any property is subject and, to the best of our knowledge, no such action against us is contemplated or threatened.

 

Item 4.Mine Safety Disclosures. 

 

This item is not applicable.

 

PART II

 

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 

 

Our common shares are quoted on the OTCQB under the symbol “DTII”.  Set forth in the table below are the quarterly high and low prices of our common stock as obtained from the OTCQB for the past two fiscal years ended April 30, 2023.

 

On June 28, 2022 the Company effected a reverse stock split of its issued and outstanding common stock on a one share for 500 shares basis. Prices set forth in the table below are adjusted to reflect that reverse stock split.

 

 

 

High

 

 

Low

 

 

 

 

 

 

Fiscal year ended April 30, 2023

 

 

 

 

 

First Quarter

$

1.25

 

$

0.10

Second Quarter

$

0.79

 

$

0.13

Third Quarter

$

0.76

 

$

0.13

Fourth Quarter

$

0.18

 

$

0.06

 

 

 

 

 

 

Fiscal year ended April 30, 2022

 

 

 

 

 

First Quarter

$

10.00

 

$

4.50

Second Quarter

$

9.85

 

$

4.00

Third Quarter

$

3.90

 

$

1.50

Fourth Quarter

$

2.75

 

$

0.40

 

As of April 30, 2023, there were approximately 144 stockholders of record of our common stock, which does not take into account those shareholders whose certificates are held in the name of broker-dealers or other nominee accounts.

 

Purchase of Equity Securities by the Issuer and Affiliated Purchasers

 

We did not purchase any of our shares of common stock or other securities during our fiscal year ended April 30, 2023.

 

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

 

During the year ended April 30, 2022 the Company issued 41,551 shares of common stock for the conversion of $132,728 of convertible debt and accrued interest.


7


During the year ended April 30, 2022 the Company issued 265,241 shares of common stock for the conversion of series C preferred shares with a value of $470,981.

 

During the year ended April 30, 2022 the Company issued 657,895 shares of series A preferred for $25,000 of convertible debt and 600 shares of series D preferred for $563,318 of convertible debt.

 

During the year ended April 30, 2023, the Company issued 731,995 shares of series B preferred for the reduction of $2,901,836 of notes payable and accrued expenses.  The issuance consisted of 279,026 shares to related parties for accrued expense of $1,074,250, 53,750 shares for the payment of $322,500 of notes payable and interest and 399,219 shares for the payment of $1,505,118 of accounts payable and accrued expenses,

 

During the year ended April 30, 2023 the Company issued 25,000 shares of series B preferred for $294,998 for service.

 

During the year ended April 30, 2023, the Company issued 1,023,626 shares of common stock for the conversion of $76,711 of convertible debt.

 

During the year ended April 30, 2023, the Company issued 292,119 shares of common stock for the conversion of 21,235 Series B preferred shares.

 

During the year ended April 30, 2023, the Company issued 79,766 shares of common stock for the conversion of 8 Series D preferred shares.

 

Dividends Policy

 

During 2022, we have declared a 7% interest in our outstanding series C convertible preferred shares with a total amount of $12,217 which was converted as of April 30, 2022.  During the year ended April 30, 2023 the Company issued a series D preferred shares with a dividend of 5% interest.  The deemed dividend was $34,645 for the year ended April 30, 2023.

 

Warrants and Options

 

During the year ended April 30, 2019 the Company issued 1,200 warrants with a conversion price of $350 to $1,250 to four individuals and 500 options with a conversion price of $500 to one individual. The warrants have a three year term and are convertible into the common shares of the Company.

 

Of the 1,250 warrants issued; the Company issued 800 warrants to Ionic Ventures as part of the convertible notes. The warrants contained an antidilution and reset provision to adjust to futures shares issued at a conversion price lower than the initial conversion price of $350.  Along with the reset provision the length of maturity of the warrants was extended. Based on the reset provisions  the number of warrants increased to 66,667 with a reset conversion price of $4.20 resulting in a down round amount of $903,270 during the year ended April 30, 2020.

 

During the year ended April 30, 2022 the issuance of shares at a strike price lower than the previous period triggered a recalculation of the number of warrants to be issued. The issuance of warrants increased by 133,213. The down round calculation on the warrants did not trigger an amount greater than the down round calculated in earlier quarters. As part of the changes, the warrants expiration dates were extended to October 30, 2023 and February 27, 2024.

 

On April 29, 2022 the Company issued 600 series D preferred shares with a value of $600,000 to Ionic Ventures in exchange for the convertible debt interest and the cancellation of all warrants outstanding. As of April 30, 2022 and 2023 there were zero warrants outstanding.


8


A summary of the Company’s stock options and warrants as of April 30, 2023, and changes during the two years then ended is as follows:

 


Options and
Warrants


Weighted
Average
Exercise Price

Weighted Average
Remaining
Contract Term
(Years)


Aggregate
Intrinsic
Value

 

 

 

 

 

 

Outstanding and exercisable at April 30, 2021

38,367

 

14.30

2.48

$ 239,861

Granted by adjustment

133,213

 

1.40

2.31

--

Forfeited or expired

1,508

 

--

--

--

Exchanged for preferred shares

(200,000)

 

--

--

--

Outstanding and exercisable as April 30, 2022

--

 

--

--

--

Granted

--

 

---

---

--

Forfeited or expired

--

 

--

--

--

Exchanged for shares

--

 

--

--

--

Outstanding and exercisable as of April 30, 2023

--

 

--

--

--

 

Item 6.  Selected Financial Data.

 

This item is not required for a smaller reporting company.

 

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations. 

 

The following information should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this Form 10-K.

 

The consolidated financial statements included in this annual report include the financial statements of the Company and those of Passive Security Scan, Inc. ("PSSI"), a consolidated subsidiary.

 

Effective January 12, 2017, PSSI was incorporated in the state of Utah as a wholly owned subsidiary.  The Company merged its wholly owned subsidiary, Long Canyon Gold Resources Corp. ("Long Canyon"), into PSSI, with PSSI the surviving entity.  The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company.  The Company currently owns 76.28% of PSSI with 23.72% acquired by four other individuals and entities.  With the merger of Long Canyon into PSSI, the Company discontinued its mineral exploration business.  The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.

 

Forward Looking and Cautionary Statements

 

This report contains forward-looking statements relating to future events or our future financial performance.  In some cases, you can identify forward-looking statements by terminology such as “may,” “will” “should," “expect," "intend," "plan," anticipate," "believe," "estimate," "predict," "potential," "continue," or similar terms, variations of such terms or the negative of such terms.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors.  Although forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements.  Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Going Concern

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern.  Through April 30, 2023, the Company had no revenue, has an accumulated deficit of $16,527,130 and a working capital deficit of $1,919,650 and expects to incur further losses in the development of its business, all of which cast substantial doubt about the Company’s ability to continue as a going concern.  Management plans to


9


continue to provide for the Company's capital needs during the year ending April 30, 2023 by issuing debt and equity securities and by the continued support of its related parties.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.  There is no assurance that funding will be available to continue the Company’s business operations.

 

Results of Operations

 

We currently have a limited source of operating revenues. Accordingly, zero revenue was recorded in the year ended April 30, 2023 and in the same period in 2022.

 

Our total operating expenses increased to $1,734,114 in the year ended April 30, 2023 from $867,597 in the year ended April 30, 2022.  The increases are due primarily to a higher development expenses and consulting fees.

 

Our interest expense decreased to $163,643 in the year ended April 30, 2023 from $203,388 in the year ended April 30, 2022. In addition, our loss on extinguishment of debt was $849,329, in the year ended April 30, 2023 compared to $36,682 in the same time in 2022. We expensed an impairment of the inventory of $40,586 during the year ended April 30, 2023 compared to zero in 2022.

 

We recognized a decrease on derivative liability to $65,826 compared to $305,232 in the years ended April 30, 2023 and 2022, respectively.  We estimate the fair value of the derivative for the conversion feature of our convertible notes payable using the American Option Binomial pricing model at the inception of the debt, at the date of conversions to equity, cash payments and at each reporting date, recording a derivative liability, debt discount and a gain or loss on change in derivative liability as applicable.  These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, and variable conversion prices based on market prices as defined in the respective loan agreements.  These inputs are subject to significant changes from period to period; therefore, the estimated fair value of the derivative liability and associated gain or loss on derivative liability will fluctuate from period to period and the fluctuation may be material.

 

We recognized a loss on extinguishment of debt of $849,329 in the year ended April 30, 2023 compared to $36,682 in the year ended April 30, 2022. The change on extinguishment of debt resulted primarily from the elimination of derivative liabilities upon debt extinguishment. This will fluctuate from period to period depending on the number of debt conversions and the associated balance of derivative liabilities, and the fluctuation may be material.

 

As a result, we recognized a net loss of $2,627,563 and net loss of $718,325 on the years ended April 30, 2023 and 2022, respectively.

 

Because we own 76.28% of PSSI as of April 30, 2023 we include 76.28% of the net loss of PSSI for the year ended April 30, 2023 in our consolidated net loss and have reported non-controlling interest of 23.72% of the net loss of PSSI, or $51,923, for the year ended April 30, 2023 and $42,701 for the same period in 2022.

 

Liquidity and Capital Resources

 

At April 30, 2023, we had total current assets of $35,316, consisting of cash of $804 and inventory of $34,512. Current liabilities at April 30, 2023 were $1,954,967 resulting in a working capital deficit of $1,919,651.  Included in our current liabilities and working capital deficit are payables to related parties of $910,524, notes payable of $179,692, accounts payable of $260,766 and derivative liabilities totaling $65,826 related to the conversion features of certain of our convertible notes payable.  We do not believe the derivative liabilities will require settlement in cash.

 

A significant portion of our current liabilities as of April 30, 2023 is comprised of amounts due to related parties of $910,524 compared to $1,554,639 for the same period in 2022.  We anticipate that in the short-term, operating funds will continue to be provided by related parties and other lenders.  


10


At April 30, 2023, we had total convertible notes payable of $319,767, net of discount.  Several of the note agreements require repayment through conversion of principal and interest into shares of the Company's common stock.  We anticipate, therefore, converting these notes payable into shares of our common stock without the need for replacement financing; however, there can be no assurance that we will be successful in accomplishing this.

 

During  the year ended April 30, 2023, we received cash proceeds of $134,650 in notes payable and repaid $30,000 in notes payable. We received $75,000, less payment of notes payable of $5,733 and the sale of preferred shares of $177,500 or a net cash received from financing activities of $246,767 during the year ended April 30, 2022.  These convertible short-term notes, which have a total principal balance of $319,767 net of discount at April 30, 2023 compared to $305,127 in 2022, bear interest at annual rates ranging from 6% to 15% per annum and are convertible into common shares of the Company upon the terms and subject to the limitations and conditions set forth in the note agreements.  The notes generally contain early repayment penalties if repaid before defined payment dates in the note agreements.

 

During the year ended April 30, 2022 we extinguished $132,728 in principal and accrued interest through conversion of convertible notes payable to common stock.

 

During the year ended April 30, 2023, net cash used in operating activities was $109,607 as a result of our net loss of $2,627,564 offset an increase in payables to related parties of $430,135, a change in accounts payable of $943,842, stocks for service of $294,998 and loss on stock issuance of $849,329.

 

During the year ended April 30, 2022, net cash used in operating activities was $285,215 as a result of our net loss of $718,325 offset by amortization of debt discount and financing costs of $96,610, change in fair value of $492,187, increase in related party payables to $304,821, and accounts payable and accrued expense of $412,842.

 

During the year ended April 30, 2023, net cash provided by financing activities was $104,650 comprised of net proceeds from notes payable of $134,650 less repayment of $30,000.

 

During the year ended April 30, 2022, net cash provided by financing activities was $246,767 comprised of net proceeds from convertible notes payable of 75,000, repayment of notes payable of $5,733 and the sale of preferred shares of $177,500.

 

We have not realized any significant revenues since inception and paid expenses and costs with proceeds from the issuance of securities as well as by loans from investor, stockholders, and other related parties.

 

Our immediate goal is to provide funding for the completion of the initial production of the Offender Alert Passive Scan licensed from CCS.  The Offender Alert Passive Scan is an advanced passive scanning system for detecting and identifying concealed threats.

 

We believe a related party and other lenders will provide sufficient funds to carry on general operations in the near term and fund PSSI’s production and sales.  We expect to raise additional funds from the sale of securities, stockholder loans and convertible debt.  However, we may not be successful in our efforts to obtain financing to carry out our business plan.

 

As of April 30, 2023, we did not have sufficient cash to fund our operations for the next twelve months.

 

Inflation

 

In the opinion of management, inflation has not and will not have a material effect on our operations until such time as we begin to realize revenues from operations.  At that time, management will evaluate the possible effects of inflation related to our business and operations following a successful acquisition or merger.


11


Net Operating Loss Carryforward

 

We have accumulated a net operating loss carryforward of approximately $7,554,918 as of April 30, 2023.  This loss carry forward may be offset against future taxable income.  The use of these losses to reduce future income taxes will depend on the generation of sufficient taxable income prior to the expiration of the net operating loss carryforward.  In the event of certain changes in control, there will be an annual limitation on the amount of net operating loss carryforward that can be used.  No tax benefit has been reported in the financial statements for the years ended April 30, 2023 and 2022 because it has been fully offset by a valuation reserve.  The use of future tax benefit is undeterminable because we presently have no operations.

 

Critical Accounting Policies

 

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to intangible assets, derivative liabilities, income taxes, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. 

 

For further information on our significant accounting policies see Note 2 to our consolidated financial statements included in this Annual Report. There were no changes to our significant accounting policies during the year ended April 30, 2023. The following is a description of those significant accounting policies that involve estimates and judgment by management.

 

Derivative Liabilities

 

We have identified the conversion features of certain of our convertible notes payable as derivatives.  We estimate the fair value of the derivatives using American Option Binomial pricing model.  We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, and a gain or loss on change in derivative liabilities as applicable.  These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility and variable conversion prices based on market prices as defined in the respective agreements.  These inputs are subject to significant changes from period to period and to management's judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

 

Basic and Diluted Loss per Common Share

 

The Company computes net loss per share in accordance with ASC 260, Earnings per Share, which requires presentation of both basic and diluted loss per share (“EPS”) on the face of the statement of operations.  Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period.  Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, convertible preferred stock, and convertible debt, using the if-converted method.  In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all potentially dilutive common shares if their effect is antidilutive.  

 

Impairment of Inventory

 

The Company reviews the carrying value of its assets annually or whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The


12


Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the asset. The Company determined although their inventory is salable, none has been sold for over 2 years, but there is a potential of obsolescence to the asset. This could occur due to refinement of the finished product or enhancement of the parts used in the product.  The Company has determined that some impairment has occurred and is reserving an impairment. As of April 30, 2023, the Company reserved $40,586 as an impairment of the value of the inventory.

 

Financial Instruments

 

Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value using a hierarchy based on the level of independent, objective evidence when measuring fair value using a hierarch based on the level of independent, objective evidence surrounding the inputs used to measure fair value.  A financial instrument’s categorization with the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The hierarchy prioritized the inputs into three levels that may be used to measure fair value:

 

Level 1:  applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2:  applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in markets that are not active.

 

Level 3:  applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

As of April 30, 2023 and 2022, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.  

 

Liabilities measured at fair value on a recurring basis were estimated as follows at April 30, 2023 and 2022:

 

Total

Level 1

Level 2

Level 3

2022

 

 

 

 

Derivative liabilities

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

2023

 

 

 

 

Derivate liabilities

$    65,826

$          --

$          --

$    65,826

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$    65,826

$          --

$          --

$    65,826

 

Impairment of Long-Lived Assets

 

The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are


13


present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. As of April 30, 2019 the Company impaired the license agreement expensing $378,600.

 

Recent Accounting Pronouncements

 

See Note 2 to our consolidated financial statements included in this Annual Report for disclosure of recent accounting pronouncements.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

This item is not required for a smaller reporting company.

 

Item 8.Financial Statements and Supplementary Data. 

 

The consolidated financial statements filed with this report are presented beginning on page F-1, immediately following the signature page.

 

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 

 

None

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

For purposes of this section, the term disclosure controls and procedures mean controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Act”) (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.  It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.  As of the end of the period covered by this Annual Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our CEO and CFO has concluded that the Company’s disclosure controls and procedures are not effective because of the identification of a material weakness in our internal control over financial reporting, which is identified below, which we view as an integral part of our disclosure controls and procedures.  

 


14


Changes in Internal Controls over Financial Reporting

 

We have not made any changes in our internal controls over financial reporting that occurred during the period covered by this Form 10-K that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act of 1934. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with generally accepted accounting principles. Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of April 30, 2023, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). Based on its evaluation, our management concluded that there are material weaknesses in our internal control over financial reporting was not effective as of April 30, 2023, and there are material weaknesses in our internal control over financial reporting. We lack full time personnel in accounting and financial staff to sufficiently monitor and process financial transactions in an efficient and timely manner. This allows for insufficient segregation of duties and a lack of multiple levels of supervision and review. Our history of losses has severely limited our budget to hire and train enough accounting and financial personnel needed to adequately provide this function.  Consequently, we lacked sufficient technical expertise, reporting standards and written policies and procedures.  A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.  

 

This Form 10-K does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to an exemption for non-accelerated filers set forth in Section 989G of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

 

Item 9B. Other Information.

 

Not applicable.

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

Our executive officers and directors are as follows:

 

Name

 

Age

 

Position

 

 

 

 

 

Merrill W. Moses

 

70

 

President, CEO, Secretary, Interim CFO and Director

 

 

 

 

 

Charles C. Hooper

  

76

  

Director

 

On April 30, 2016, the Board of Directors appointed Merrill W. Moses to replace Stephen M. Studdert as a director, President, CEO, acting CFO and Secretary of the Company.


15


 

On May 20, 2016, the Board of Directors appointed Charles C. Hooper to replace Frank Thorwald as a director.

 

On June 30, 2023, Charles Hooper resigned from the Board of Directors.

 

All directors serve for a one-year term until their successors are elected or they are re-elected at the annual stockholders' meeting. Officers hold their positions at the pleasure of the board of directors, absent any employment agreement, of which none currently exists or is contemplated.

 

We presently anticipate that we will consider new, qualified persons to become directors in the future, although no new appointments or arrangements have been made as of the date hereof.

 

There is no arrangement, agreement or understanding between any of the directors or officers and any other person pursuant to which any director or officer was or is to be selected as a director or officer. Also, there is no arrangement, agreement or understanding between management and non-management stockholders under which non-management stockholders may directly or indirectly participate in or influence the management of our affairs.

 

The business experience of each of the persons listed above during the past five years is as follows:

 

Merrill W. Moses attended Brigham Young University and over the past 40 years has been an entrepreneur and founder of a variety of independent business ventures.  He has also been involved in operating an independent oil and gas company and a mining and exploration company.  Since 1992, Mr. Merrill has served as President and CEO of two oil and gas companies, Energy Pro Inc. and Dynamic Energy & Petroleum Inc.  Mr. Moses is also a founding partner in 2007 of Liberty Capital International, Inc., an international financial and project management company that provides various private client financial and asset management services.

 

Charles C. Hooper has a background in Mineral Exploration and Mining and currently is the owner of Old Town Financial in La Jolla, California, a designer, financier and developer of commercial buildings and other real estate projects. Previously, he was a missile guidance engineer designing and building missile guidance systems for the U.S. Army. Mr. Hooper also served as an officer in the U.S. Navy during the Viet Nam war. He is a graduate system engineer from the University of California at Los Angeles and holds a Master of Science Degree in Management.

 

None of our officers, directors or control persons has had any of the following events occur:

 

any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer, either at the time of the bankruptcy or within two years prior to that time. 

 

any conviction in a criminal proceeding or being subject to a pending criminal proceeding, excluding traffic violations and other minor offenses. 

 

being subject to any order, judgment or decree, not substantially reversed, suspended or vacated, of any court of competent jurisdiction, permanently enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking business; and 

 

being found by a court of competent jurisdiction in a civil action, the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated. 

 

No director is deemed to be an independent director. Our board of directors performs some of the functions associated with a nominating committee and a compensation committee, including reviewing all forms of compensation provided to our executive officers, directors, consultants and employees, including


16


stock compensation. The board will also perform the functions of an audit committee until we establish a formal committee.

 

Compliance With Section 16(a) of the Exchange Act

 

Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of our common stock, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities.  We believe that no reports were filed during the fiscal year 2022.

 

Code of Ethics

 

We currently do not have a code of ethics.  We do intend to adopt a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions

 

Item 11. Executive Compensation.

 

We do not have a bonus, profit sharing, or deferred compensation plan for the benefit of employees, officers or directors.  We currently have no employees and do not pay any salaries.  Compensation for our officers and directors is generally established through a written Service Agreement.

 

The following table depicts compensation accrued to officers and directors for the fiscal years ended April 30, 2023, 2022 and 2021.

 

 

Name and Principal Position

Year Ended

April 30,

 

Salary

 

Bonus

All Other

Consideration

 

Total

Merrill W. Moses, President, CEO, Secretary, Interim CFO and Director (1)(1)

2023

2022

2021

$    0

$    0

$    0

$    0

$    0

$    0

$       150,000

$     150,000

$     150,000

$   150,000

$   150,000

$   150,000

Charles Cortland Hooper, Director (2)

2023

2022

2021

$    0

$    0

$    0

$    0

$    0

$    0

$         60,000

$       60,000

$       60,000

$     60,000

$     60,000

$     60,000

 

(1)Mr. Moses’ compensation for services as President, CEO, Secretary, Interim CFO and Director was accrued pursuant to a Service Agreement with the Company dated April 25, 2016.  As of April 30, 2023, $67,500 was payable to Mr. Moses by the Company.  In addition, pursuant to a Service Agreement with Passive Security Scan Inc. (“PSSI”), compensation of $45,000 was accrued for the year with the total payable from both Companies of $112,500 as of April 30, 2023.  

 

(2)Mr. Hooper’s compensation for the fiscal year ended April 30, 2023 was $60,000 with $45,000 accrued as a payable to Mr. Hooper.  The compensation for services as Director was accrued pursuant to a Service Agreement dated May 20, 2016.   

 

During the fiscal year ended April 30, 2023, we accrued expenses and services rendered by EMAC in the amount of $290,556 pursuant to Administration Agreements with DTII and $462,470 with PSSI.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related

 Stockholder Matters. 

 

The following table sets forth certain information as of April 30, 2023 with respect to the beneficial ownership of our common stock and based on 1,803,042 shares outstanding:

 

Each stockholder believed to be the beneficial owner of more than 5% of our common stock. 


17


 

by each of our directors and executive officers; and 

 

all of our directors and executive officers as a group. 

 

For purposes of the following table, a person is deemed to be the beneficial owner of any shares of common stock (I) over which the person has or shares, directly or indirectly, voting or investment power, or (ii) of which the person has a right to acquire beneficial ownership at any time within 60 days after the date of this report. “Voting power” is the power to vote or direct the voting of shares and “investment power” includes the power to dispose or direct the disposition of shares.

 

Name and Address

Amount and Nature of

Percent

of Beneficial Owner

Beneficial Ownership(1)

of Class

 

 

 

Directors and Executive Officers:

 

 

Merrill W. Moses, President & CEO
4730 S. Fort Apache Road, Suite 300
Las Vegas, Nevada 89147

2,001

0.1%

Charles C. Hooper, Director
4730 S. Fort Apache Road, Suite 300
Las Vegas, Nevada 89147

1

0.00%

All directors and executive officers
as a group (2 person)

2,002

0.1%

 

(1)Unless otherwise indicated, the named person will be the record and beneficially owner of the shares indicated. 

 

The following persons hold preferred shares that carry super voting power and are convertible into shares of the company’s common stock. The following table indicates the person and the number of preferred and common shares held and the voting power representing the preferred shares.

 

 

 

 

 

 

 

Percent

Of Voting Power(3)

5% Beneficial Owners:

 

 

 

 

 

AMC Services GmbH, Daniel Lacher, Control Person,        

 

preferred

390,234 (39,032,400 votes)

 

95.6%

     Alte Greifenseestrasse 16, Volketswil/Switzerland

 

 

 

 

 

 

 

 

 

 

 

Emac Handels AG, Reinhard Hiestand, Control Person,      

 

preferred

2,283,135 (228,313,500 votes)

 

      Churerstr. 106, Pfaeffikon/Switz

 

common

2,750

 

99.2%

 

 

 

 

 

 

 

 

 

 

 

 

Velania Treuhand AG, Reinhard Hiestand, Control Person,

 

preferred

252,000 (25,200,000 votes)

 

93.3%

      Churerstr. 106, Pfaeffikon/Switz

 

 

 

 

 

 

 

 

 

 

 

 

(1)Unless otherwise indicted, the named person will be the record and beneficial owner of the shares indicated. 

(2)Percentage ownership is based on 1,803,042 shares of common stock and 2,925,369 Preferred Series A Stock (Equal to 295,236,900 votes) outstanding as of April 30, 2023. 

(3)Assumes the named shareholder, and only the name shareholder, exercises the common stock voting power of the Series A Preferred Stock equal to 100 common stock votes per each share of preferred stock. 


18


 

Item 13.  Certain Relationships and Related Transactions, and Director Independence.

 

Except as set forth below, we have not entered into any other material transactions with any officer, director, nominee for election as director, or any stockholder owning greater than five percent (5%) of our outstanding shares, nor any member of the above referenced individuals' immediate family.

 

During the years ended April 30, 2023 and 2022, management and administrative services were compensated by the Company pursuant to: a Service Agreement between the Company and Merrill Moses, President, CEO, Secretary, acting CFO and director, dated April 25, 2016; a Service Agreement between the Company and Charles Hooper, director, dated May 20, 2016; a Service Agreement between the Company; and an Administration Agreement with EMAC Handles AG (“EMAC”), a shareholder of the Company and PSSI, executed on March 15, 2011 and renewed on May 1, 2014.  

 

During the year ended April 30, 2023, management and administrative services were compensated by PSSI pursuant to a Service Agreement between PSSI and Merrill Moses, dated January 12, 2017 and effective February 1, 2017 and an Administration and Management Agreement dated January 12, 2017 between PSSI and RAB Investments AG (“RAB”), a significant lender of the Company and a shareholder of PSSI.

 

The fees are based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with the Company’s common stock.  The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay.  These types of transactions, when incurred, result in payables to related parties in the Company's consolidated financial statements as a necessary part of funding the Company's operations.

 

On December 11, 2018, the Board of Directors resolved to change the terms of the company’s Series A and Series B Preferred Shares from ten (10) shares of DTII common stock for each one (1) share of Preferred Stock, to five (5) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms applied to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock. On May 9, 2019, DTII’s Board of Directors unanimously resolved to revise the terms of the company’s Series A and Series B Preferred Shares. Under the new terms, the conversion right of both Series A and B Preferred Shares was changed from five (5) shares of DTII common stock for each one (1) share of Preferred Stock, to a new conversion right of ten (10) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms apply to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock. The Board received the unanimous consent to the changed terms from each current Preferred shareholder.

 

As of April 30, 2023, the Company and PSSI had the following consolidated payable balances due to related parties, which resulted from transactions with significant shareholders and officers and directors of the Company.

 

EMAC

$753,024

Merrill Moses, President, CEO, Secretary, acting CFO & director

112,500

Charles Hooper, director

45,000

 

$910,524

 

None of our directors are deemed to be independent directors.  We do not have a compensation, audit or nominating committee, rather those functions are carried out by the board as a whole.


19


 

Item 14.  Principal Accounting Fees and Services.

 

The following tables present for each of the last two fiscal years the aggregate fees billed in connection with the audits of our financial statements and other professional services rendered by our independent registered public accounting firm Fruci & Associates II, PLLC :

 

 

2023

2022

Audit fees

$

67,000

$            50,132

Audit related fees

 $

--

$              --

Tax fees

$

--

$              --

All other fees

 $

--

$              --

 

Audit fees represent the professional services rendered for the audit of our annual financial statements and the review of our financial statements included in quarterly reports, along with services normally provided by the accounting firm in connection with statutory and regulatory filings or engagements.  Audit-related fees represent professional services rendered for assurance and related services by the accounting firm that are reasonably related to the performance of the audit or review of our financial statements that are not reported under audit fees.

 

Tax fees represent professional services rendered by the accounting firm for tax compliance, tax advice, and tax planning.  All other fees represent fees billed for products and services provided by the accounting firm, other than the services reported for in the other categories.

 

PART  IV

 

Item 15.  Exhibits, Financial Statement Schedules

 

(a)Exhibits 

 

Exhibit No.

 

Exhibit Name

 

 

 

 3.1 (2)

 

Articles of Incorporation and amendments thereto

 3.2 (1)

 

Bylaws

 4.1 (2)

 

Instrument defining security holder rights

21.1

 

Subsidiaries

31.1

 

Certification of Chief Executive Officer and Interim Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

 

Certification of Chief Executive Officer and Interim Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101 INS*

 

XBRL Instance Document

101 SCH*

 

XBRL Schema Document

101 CAL*

 

XBRL Calculation Linkbase Document

101DEF*

 

XBRL Definition Linkbase Document

101 LAB*

 

XBRL Labels Linkbase Document

101 PRE*

  

XBRL Presentation Linkbase Document

 

*The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

 

(1)Filed as exhibit to Form S-1 filed on November 10, 2011. 

(2)Filed as exhibit to Amendment No. 1 to Form S-1 filed on March 12, 2012. 


20


SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Defense Technologies International Corp.

 

 

 

 

By:

/S/ MERRILL W. MOSES

 

 

Merrill W. Moses

 

 

Chief Executive Officer

 

 

Dated: August 18, 2023

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/S/ MERRILL W. MOSES

 

Director

 

August 25, 2023

Merrill W. Moses

 

 

 

 

 

 

 

 

 

/S/ CHARLES C. HOOPER

 

Director

 

August 25, 2023

Charles C. Hooper

 

 

 

 


21


 

 

Defense Technologies International Corp. and Subsidiary

 

Index to Consolidated Financial Statements

 

Years Ended April 30, 2023 and 2022

 

Report of Independent Registered Public Accounting Firm

F-2

 

 

Consolidated Balance Sheets as of April 30, 2023 and 2022

F-4

 

 

Consolidated Statements of Operations for the Years Ended April 30, 2023 and 2022

F-5

 

 

Consolidated Statements of Stockholders’ Deficit for Years Ended April 30, 2023 and 2022

F-6

 

 

Consolidated Statements of Cash Flows for the Years Ended April 30, 2023 and 2022

F-7

 

 

Notes to the Consolidated Financial Statements

F-8


F-1


 

 

Picture 1 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of Defense Technologies International Corp.

 

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Defense Technologies International Corp. (“the Company”) as of April 30, 2023, and 2022, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-year period ended April 30, 2023, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2023, and 2022 and the results of its operations and its cash flows for each of the years in the two-year period ended
April 30, 2023, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has had no revenue, an accumulated deficit, and working capital deficiency. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Accounting for Embedded Conversion Features on Notes Payable

Critical Audit Matter Description

As discussed in Note 6 to the consolidated financial statements, the Company has issued and outstanding several notes payable during the year with conversion rates that are adjustable at a discounted rate to market prices. The terms allow for variable amounts of shares to be converted for a set dollar value; this and other factors require the embedded


F-2


conversion feature to be bifurcated and evaluated at each reporting period. Calculations and accounting for the notes payable and embedded conversion features require management’s judgments related to initial and subsequent recognition of the debt and related conversion features, use of a valuation model, and determination of appropriate inputs used in the selected valuation model.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to evaluating the Company’s accounting for notes payable and related accounts included the following, among others:

·Confirmation of notes payable and related terms. 

·Independent assessment of the appropriate valuation model for derivatives, performing independent calculations based on the model and comparing the Company’s results to a reasonable range as determined during the audit. 

·Testing of substantially all transactions related to this matter.  

Image 

 

Fruci & Associates II, PLLC – PCAOB ID #05525

We have served as the Company’s auditor since 2017.

 

Spokane, Washington

August 25, 2023

 

 


F-3


 

 

Defense Technologies International Corp. and Subsidiary

Consolidated Balance Sheets

 

April 30,

2023

2022

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

  Cash

$   804

$  5,761

  Inventory

34,512

69,649

  Total current assets

35,316

75,407

 

 

 

Fixed assets , net of depreciation of $34,911 and $26,235

--

8,676

Total assets

$    35,316

$  84,083

 

 

 

 

Current liabilities:

 

 

  Accounts payable and accrued expenses

 $ 260,765

$   700,921

  Accrued license agreement payment

37,500

171,300

  Accrued interest and fees payable

150,517

147,877

  Customer deposits

30,375

30,375

  Derivative liabilities

65,826

305,232

  Convertible notes payable, net of discount

319,767

305,127

  Payables – related parties

910,524

1,554,639

  Notes payable

64,092

375,042

  Notes payable- related party

115,600

--

    Total current liabilities

1,954,966

3,590,513

 

 

 

     Total liabilities

1,954,966

3,590,513

 

 

 

Commitments and contingencies

--

--

 

 

 

Stockholders’ deficit

 

 

 

 

 

Convertible preferred stock, $0.0001 par value; 20,000,000 shares authorized: Series A – 2,925,369 and 3,583,264 shares issued and outstanding, respectively

292

358

Series B – 1,913,655 and 520,000 shares issued and outstanding, respectively

191

52

Common stock, $0.0001 par value; 600,000,000 shares authorized,1,803,042 and 487,408 shares issued and outstanding, respectively, post reverse split

181

49

  Additional paid-in capital

14,905,851

10,657,067

  Accumulated deficit

(16,527,130)

(13,916,844)

     Total

(1,620,615)

(3,259,318)

  Non-controlling interest

(299,035)

(247,112)

  Total stockholders’ deficit

(1,919,650)

(3,506,430)

Total liabilities and stockholders’ deficit

$  35,316

$   84,083

 

The accompanying notes are an integral part of these consolidated financial statements


F-4


 

Defense Technologies International Corp. and Subsidiary

Consolidated Statements of Operations

 

 

Years Ended April 30,

2023

2022

 

 

 

Revenue

$          --

$               --

Cost of goods

--

--

 

 

 

Operating expenses:

 

 

  Consulting fees

1,180,900

495,000

  Depreciation

8,675

11,660

  Development

259,243

--

  General and administrative

285,297

360,937

 

 

 

  Total operating expenses

1,734,115

867,597

 

 

 

Loss from operations

(1,734,115)

(743,128)

 

 

 

Other income (expense):

 

 

  Loss on stock issuance  

--

(65,007)

  Gain (loss) on notes payable

--

(21,610)

  Finance and interest cost on notes

--

(7,500)

  Impairment of asset

(40,586)

--

  Inventory adjustment

(5,397)

(8,728)

  Interest expense including penalty and debt discount

(163,643)

(203,388)

  Gain (loss) on derivative liabilities

165,506

492,187

  Gain (loss) on extinguishment of debt

(849,329)

(36,682)

 

 

 

  Total other income (expense)

(893,449)

149,272

 

 

 

Gain(loss) before income taxes

(2,627,564)

(718,325)

 

 

 

Provision for income taxes

--

--

 

 

 

Net gain (loss)

(2,627,564)

(718,325)

 

 

 

Non-controlling interest in net loss of consolidated subsidiary

51,923

42,701

 

 

 

Net gain (loss) attributed to the Company

$ (2,575,641)

$  (675,624)

 

 

 

 

 

 

Net loss per common share – basic and diluted

$   (384.74)

$    (2.25)

 

 

 

Weighted average shares outstanding – basic and diluted

670,681

299,712

 

The accompanying notes are an integral part of these consolidated financial statements


F-5


Defense Technologies International Corp. and Subsidiary

Consolidated Statements of Stockholders’ Deficit

For the Years Ended April 30, 2023 and 2022

 

 

 

 

Additional
Paid-In
Capital

Accumulated
Deficit

Non-Controlling
Interest

Total

Stockholders’

Deficit

 

Preferred

stock

 

Common Stock

Shares

Amount

 

Shares

Amount

Balance at April 30, 2021

3,690,069

 344

 

180,485

 18

9,218,754

(13,229,003)

(204,411)

$( 4,214,298)

Common stock issued for preferred shares

(450,700)

--

 

265,241

27

469,552

--

--

469,579

Common stock issued for convertible debt

--

--

 

41,551

4

132,724

--

--

132,728

Temporary equity- Preferred shares issued for cash

206,000

-

 

--

--

--

--

--

--

Temporary equity- preferred shares issued for debt

600

--

 

--

--

--

--

--

--

Deemed dividend on preferred shares

--

--

 

--

--

--

(12,217)

--

(12,217)

Preferred shares issued for convertible debt

657,895

7

 

--

--

24,993

 

 

25,000

Retirement of derivative at conversion

--

--

 

-

--

211,103

--

--

211,103

Rounding shares due to reverse of shares

--

--

 

131

--

--

--

--

--

Net loss

--

--

 

--

--

--

(675,624)

(42,701)

(718,325)

Balance at April 30, 2022 (reclassified)

4,103,864

410

 

487,408

49

$10,657,067

(13,916,844)

 (247,112)

(3,506,430)

Common stock issued for convertible debt

 

--

 

1,023,626

102

76,609

--

--

76,711

Common stock issued for preferred shares conversion

(21,235)

--

 

212,353

29

(29)

--

--

--

Preferred shares issued to related parties

279,026

28

 

--

--

1,074,222

--

--

1,074,250

Preferred shares issued for accrued expense

399,219

39

 

--

--

1,505,118

--

--

1,505,157

Preferred shares issued for service

25,000

2

 

--

--

294,995

--

--

294,997

Preferred shares reclassified to equity

--

--

 

--

1

17,499

--

--

17,500

Preferred shares for notes payable

53,750

4

 

--

--

322,496

--

--

322,500

Common stock issued for conversion of D shares

(8)

-

 

79,766

-

--

--

--

--

Retirement of derivative at conversion

 

--

 

--

--

73,900

--

--

73,900

Loss on debt settlement

 

--

 

--

--

849,329

--

--

849,329

Deemed dividend on preferred shares

 

--

 

--

--

34,645

(34,645)

--

--

Common shares returned

 

--

 

(111)

--

 

--

--

--

Net loss

 

--

 

--

--

--

(2,575,641)

(51,923)

(2,627,564)

Balance at April 30, 2023

4,839,616

$ 483

 

1,803,042

$   181

$14,905,851  

$(16,527,130)

$ (299,035)

$(1,919,650)

The accompanying notes are an integral part of these consolidated financial statements


F-6


Defense Technologies International Corp and Subsidiary

Consolidated statement of Cash Flows for Years Ended April 30,

 

2023

2022

Cash flows from operating activities:

 

 

  Net gain (loss)

$    (2,627,564)

$  (718,325)

  Adjustments to reconcile net loss to net cash
    used in operating activities:

 

 

    Depreciation

8,676

11,660

    Shares issued for service

294,998

--

    Amortization of debt discount and financing fees

91,350

96,160

    (Gain) loss on derivative liabilities

(165,506)

(492,187)

    (Gain) loss on extinguishment of debt

--

36,682

    Gain (loss) on issuance of convertible notes

--

(21,610)

    Loss on stock issuance

849,329

65,007

    Change in operating assets and liabilities:

 

 

        (Increase) decrease in inventory

35,134

(265)

        Increase in accounts payable and accrued expense

973,841

412,842

        Prepaid

--

20,000

        Increase in payables – related parties

430,135

304,821

  Net cash used in operating activities

(109,607)

(285,215)

 

 

 

Cash flows from financing activities:

 

 

 Temporary equity from preferred shares for cash

--

177,500

 Proceeds from notes payable- related party

134,650

--

  Proceeds from convertible notes payable, net

--

75,000

  Proceeds (repayment) from notes payable

(30,000)

(5,733)

Net cash provided by financing activities

104,650

246,767

 

 

 

Net increase (decrease) in cash

(4,957)

(38,448)

Cash at beginning of the year

5,761

44,209

Cash at end of the year

$       804

$        5,761

 

 

 

Supplement Disclosures

 

 

 Interest paid

$            --

$               --

 Income tax paid

$            --

$               --

 

 

 

Non-Monetary Transactions

 

 

Interest accrued on preferred shares

$    34,645

$       12,217

Common stock issued for convertible debt

$    76,711

$     132,728

Common stock issued for conversion of preferred shares

$            --

$     470,982

Retirement of derivative liability on debt conversion

$    73,900

$     211,103

Derivative liabilities for day 1 on tainted convertible notes

$            --

  $       90,656

Preferred shares issued for convertible debt

$  322,499

$     563,318

Preferred shares  issued for payment of debt

$1,505,157

$      25,000

Preferred shares issued for accrued liabilities – related party

$1,074,250

$              --

 

The accompanying notes are an integral part of these consolidated financial statements


F-7


Defense Technologies International Corp. and Subsidiary

Notes to Consolidated Financial Statements

Years Ended April 30, 2023 and 2022

 

 

NOTE 1 - NATURE OF BUSINESS AND CONTINUED OPERATIONS

 

Defense Technologies International Corp. (the "Company ") was incorporated in the State of Delaware on May 27, 1998.  Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to represent the Company’s expansion goals more fully into the advanced technology sector.

 

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.

 

On January 19, 2018, the Board of Directors, with the approval of a majority of the shareholders, passed a resolution to affect a reverse split of the Company’s outstanding common stock on a 1 share for 1,500 shares (1:1500) basis. The reverse split was effective on March 20, 2018. The number of shares in the financials are reflective of the reverse split.  

 

On June 28, 2022, the Company received approval for a reverse split of its common shares of 1:500. As a result of the reverse split all common shares in the 10-K are restated with the number of shares effected by the reverse.

 

Going Concern

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern.  Through April 30, 2023, the Company had no revenue, has accumulated deficit of $16,527,130 and a working capital deficit of $1,919,650 and expects to incur further losses in the development of its business, all of which cast substantial doubt about the Company’s ability to continue as a going concern.  Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2023 by issuing debt and equity securities and by the continued support of its related parties.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.  There is no assurance that funding will be available to continue the Company’s business operations.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.  The Company’s fiscal year end is April 30.  

 

Recent Accounting Pronouncements

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by


F-8


removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas.  The ASU is effective for annual and interim periods beginning after December 31, 2021 and early adoption is permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company has evaluated the impact that this new guidance will have on its financial statements and concluded there will be no change.

 

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or results of operations.

 

Consolidation and Non-Controlling Interest

 

These consolidated financial statements include the accounts of the Company, and its wholly owned subsidiary, Long Canyon, through January 15, 2017, and its majority-owned subsidiary, PSSI, from its formation on January 15, 2017.  All inter-company transactions and balances have been eliminated.

 

The non-controlling interest in PSSI, representing 10,883 common shares, or 23.72%, was acquired by several individuals and entities, including related parties, in exchange for services valued at $6,100 and the extinguishment of Company accounts payable – related parties with a book value of $9,835.

 

Reclassification

 

The Company is reclassing the equity section of the consolidated balance sheet for the year ended April 30, 2022, due to a reclassification of series D preferred from mezzanine equity to equity. Initially, the 600 shares of series D preferred were presented in mezzanine equity. The reclassification reduces the mezzanine equity from 600,000 to zero and increase paid in capital to 600,000. Although the series D preferred were in the settlement of convertible notes, and the convertible into common stock, the conversion feature is not set and at the election of the board of directors. The Company also reclassed series A preferred shares increasing the preferred A shares by 59 reducing paid in capital by the same amount. The impact of the reclassification effect only balance sheet presented as of April 30, 2022.

 

Impairment of Inventory

 

The Company reviews the carrying value of its assets annually or whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the asset. The Company determined although their inventory is salable, none has been sold for over 2 years, but there is a potential of obsolescence to the asset. This could occur due to refinement of the finished product or enhancement of the parts used in the product.  The Company has determined that some impairment has occurred and is reserving an impairment. As of April 30, 2023, the Company reserved $40,586 as an impairment of the value of the inventory.

 

Basic and Diluted Net Loss per Share

 

The Company computes net loss per share in accordance with ASC 260, Earnings per Share, which requires presentation of both basic and diluted loss per share (“EPS”) on the face of the statement of operations.  Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted


F-9


average number of common shares outstanding (denominator) during the period.  Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, convertible preferred stock, and convertible debt, using the if-converted method.  In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all potentially dilutive common shares if their effect is antidilutive.  

 

As of April 30, 2023, convertible debt and related accrued interest payable plus conversion of A, B and D preferred shares are convertible into 48,924,638 shares of the Company’s common stock.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes.  The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse.  The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.  The actual results experienced by the Company may differ materially and adversely from the Company’s estimates.  To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Financial Instruments

 

Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value using a hierarchy based on the level of independent, objective evidence when measuring fair value using a hierarch based on the level of independent, objective evidence surrounding the inputs used to measure fair value.  A financial instrument’s categorization with the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy prioritized the inputs into three levels that may be used to measure fair value:

 

Level 1:  applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2:  applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in markets that are not active.

 

Level 3:  applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 


F-10


As of April 30, 2023 and 2022, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.

 

Liabilities measured at fair value on a recurring basis were estimated as follows at April 30, 2023 and 2022:

 

Total

Level 1

Level 2

Level 3

2022

 

 

 

 

Derivative liabilities

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$     305,232

$          --

$          --

 $  305,232

 

 

 

 

 

2023

 

 

 

 

Derivate liabilities

$   65,826

$          --

$          --

$    65,826

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$   65,826

$          --

$          --

$   65,826

 

Derivative Liabilities

 

We have identified the conversion features of certain of our convertible notes payable as derivatives.  We estimate the fair value of the derivatives using the Black-Scholes pricing model.  We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, and a gain or loss on change in derivative liabilities as applicable.  These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility and variable conversion prices based on market prices as defined in the respective agreements.  These inputs are subject to significant changes from period to period and to management's judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

 

Non-Monetary Transactions

 

All issuances of the Company’s common stock for non-cash consideration have been assigned a dollar amount equaling either the market value of the shares issued, or the value of consideration received whichever is more readily determinable.  The majority of the non-cash consideration received pertains to services rendered by consultants and others and has been valued at the market value of the shares issued.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and consultants in accordance with FASB ASC 718. Stock-based compensation to employees is measured at the grant date, based on the fair value of the award, and is recognized as expense over the requisite employee service period. The Company estimates the fair value of stock-based payments using the Black Scholes option-pricing model for common stock options and warrants and the closing price of the Company’s common stock for common share issuances.

 

Cash and Cash Equivalents

 

The Company considers all investments purchased with original maturity of three or fewer months to be cash equivalents.

 


F-11


 

Inventory

 

Inventories are stated at the lower or cost of market using the first-in; first-out (FIFO) cost method of accounting. The inventory consists of raw materials used to make products, work in progress of zero and finished goods for sale with a total value of inventory after impairment of $34,512.

 

Equipment

 

Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets which is 36 months. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.

 

NOTE 3 – LICENSE AGREEMENT

 

Effective July 15, 2016, the Company executed documents intended to finalize the acquisition of 100% of Defense Technology Corporation, a non-related privately held Colorado company ("DTC"), a developer of defense, detection and protection products to improve security for Anchor schools and other public facilities.  Subsequently, the Company and DTC mutually agreed to rescind the acquisition of DTC and entered into a Rescission Agreement and Mutual Release (the "Rescission Agreement"), dated October 17, 2016.

 

In connection with the Rescission Agreement with the Company, DTC rescinded its agreement with the inventor and developer of the technology and assets that were subject to the original agreement between the Company and DTC.  On October 19, 2016, the Company entered into a new Definitive Agreement with Controlled Capture Systems, LLC ("CCS"), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement.  Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements.  The term of the License Agreement will be from October 19, 2016 until the expiration of the last to expire of the licensed issued patents or patents to be issued.

 

The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties at the end of each six-month period at the rate of the greater of 5% of gross sales used or sold, or the minimum royalty payment of $25,000.  The Company also agreed to compensate investors that have provided funding for the development of CCS's technology with 5 shares of the Company's common stock.  Additionally, CCS will be entitled to receive 1 shares of the Company's common stock upon completed sales of 1,000 passive scanner units based on the CCS technology.

 

The Independent Contractor Agreement between the Company and CCS provides that CCS will provide support for the development of the security technology and products.  An initial payment of $5,000 was paid to CCS plus ongoing hourly compensation for services provided.

 

The Company capitalized the costs to acquire the License Agreement, including the $25,000 initial licensing fee and the estimated value of $353,600 of the 5 shares of the Company's common stock issued on November 10, 2016 to the CCS investors, which value was based on the closing market price of the Company's common stock on the date of the Definitive Agreement. The Company has recorded a current liability of $37,500 in its consolidated balance sheet as of April 30, 2023 and $171,300 as of April 30, 2022. The decrease in amount owed from year 2023 to 2022 is due to the conversion of debt to preferred shares during the fiscal year ended April 30, 2023. Once sales of products based on the CCS technology begin, the Company will amortize the capitalized costs over the estimated life of the license agreement as determined by the legal life of patents issued.


F-12


 

On January 15, 2017, the Company transferred the License Agreement to PSSI in exchange for 15,000,000 common shares of PSSI, or 65.38% ownership. During the FY 2018 the Company increased its ownership of PSSI to 17,500,000 shares or 76.28% of the Company. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.

 

On January 22, 2017, the Company and CCS entered into an Amendment to the Definitive Agreement, whereby CCS consented to the transfer of the Definitive Agreement, Patent License Agreement, and Independent Contractor Agreement to PSSI and agreed to extend the due dates of certain payments due CCS to April 30, 2017. In exchange, CCS received 100,000 shares of PSSI common stock.

 

Also, in connection with the Amendment to the Definitive Agreement, the investors that provided funding for the development of CCS's technology received 500,000 shares of PSSI common stock.

 

The Company reviewed its valuation of the license agreement and as of April 30, 2019 the Company elected to fully impair its licenses agreement resulting in an impairment loss of $378,600.

 

NOTE 4 - RELATED PARTY TRANSACTIONS

 

Payables – Related Parties

 

During the years ended April 30, 2023 and 2022, management and administrative services were compensated by the Company pursuant to: a Service Agreement between the Company and Merrill Moses, President, CEO, Secretary, acting CFO and director, dated April 25, 2016; a Service Agreement between the Company and Charles Hooper, director, dated May 20, 2016; and an Administration Agreement with EMAC Handles AG (“EMAC”), a shareholder of the Company and PSSI, executed on March 15, 2011 and renewed on May 1, 2014.  

 

During the year ended April 30, 2022, management and administrative services were compensated by PSSI pursuant to a Service Agreement between PSSI and Merrill Moses, dated January 12, 2017 and effective February 1, 2017 and an Administration and Management Agreement dated January 12, 2017 between PSSI and RAB Investments AG (“RAB”), a significant lender of the Company and a shareholder of PSSI.

 

The fees are based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with the Company’s common stock.  The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay.  These types of transactions, when incurred, result in payables to related parties in the Company's consolidated financial statements as a necessary part of funding the Company's operations.

 

Previously on December 11, 2018, the Board of Directors resolved to change the terms of the company’s Series A and Series B Preferred Shares from ten (10) shares of DTII common stock for each one (1) share of Preferred Stock, to five (5) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms applied to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock.

 

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $115,600 plus accrued interest.

 

During the year ended April 30, 2023, the Company entered into a loan agreement with Star Anchor, a related party, for short term loans. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $19,050 plus accrued interest.

 


F-13


During the year ended April 30, 2023, the Company issued 279,026 series B preferred shares to three related parties for the payment of $1,074,250 of accrued expenses.

 

As of April 30, 2023 and 2022, the Company had payable balances due to related parties totaling $910,524 and $1,554,639, respectively, which resulted from transactions with shareholders, officers and directors of the Company.

 

NOTE 5 - NOTES PAYABLE

 

On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment fund generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

 

On July 6, 2018, the Company signed an investment agreement with a third party. Under the terms of the agreement the Company receive $250,000 through the Company attorney’s trust account. On July 12, 2018, the Company received the $250,000 less wire and legal payment of $10,045. In addition, the note holder will receive a royalty of 5% up to $250,000 and then a royalty of 3.5% for two years thereafter. The noteholder will receive 300 shares of the Company’s common stock plus 200 warrants to purchase common shares within three years at $1,250 per share.  As of April 30, 2023, the warrants had expired. On July 29, 2022, the Company issued 53,750 shares of series B preferred for the outstanding principal of $300,000 and interest of $22,500 leaving the balance due at zero.

 

On July 18, 2018, the Company entered into a promissory note of $114,226.26 with interest rate of 8% per annum with Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is to pay Haynie $5,000 per month. In addition, the Company shall pay the noteholder 20% of any funding event of private or public equity. As of April 30, 2023 the Company owed the note holder $20,042 plus interest. As of April 30, 2023 the note is in default.

 

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum.  As of January 31, 2023, the outstanding balance on the loan agreement was $115,600 plus accrued interest.

 

During the year ended April 30, 2023, the Company entered into a loan agreement with Star Anchor for short term loans. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $19,050 plus accrued interest.

 

As of April 30, 2023 and 2022, the outstanding balances of notes payable was $175,692 and $375,042, respectively.

 

NOTE 6 - CONVERTIBLE DEBT

 

On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $25 per share.  The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of April 30, 2023 the balance of the notes was $7,000 plus interest.

 

On February 16, 2018 Passive Security Scan Inc, a subsidiary of the Company issued a $20,000 convertible note to Stuart Young. The note bears interest at 6% and is convertible after 6 months from the date of the note into stock of either PSSI or the Company at 50% discount to the 10 day trailing trading value of the Company’s common stock.  

 


F-14


On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment fund generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

 

On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $330,626 which included the additional interest and retired the original notes. The Company issued shares of series A preferred with a value of $ 25,000 for payment against the convertible note.  On April 28, 2023 the Company issued 145,000 shares of common stock with a value of $7,250 for payment against the note.  As of April 30, 2023, the outstanding balance of the notes were $278,376 plus interest.

 

On January 13, 2020, the Company issued an additional note to Ionic Ventures, LLC for $220,000 with an original discount of $20,000.  The note is part of a securities purchase agreement dated August 31, 2018. The note matures on June 20, 2020 bearing interest at the rate of 15% per annum. The note is convertible into common stock of the Company at $300 per share or of 60% of the lowest trading price for twenty days prior to conversion, whichever is the lowest.  The note and all subsequent notes from Ionic contain reset provisions.  Based on the reset provision the conversion price as of April 30, 2021 was $4.20 per share.  An additional $5,000 was added to the note for note extension leaving the balance as of April 30, 2021 of $225,000. On April 29, 2022 the Company issued 600 shares of series D convertible preferred with a value of $600,000 for the payment of $563,318 of convertible debt and accrued interest plus the calculation of warrants outstanding to Ionic Ventures cancelling both notes to Ionic Ventures.  As a result of this transaction the Company incurred a loss on settlement of debt of $36,682.

 

During the year ended April 30, 2022, the Company issued 41,551 shares of common stock in the conversion of $132,728 convertible notes and accrued interest.

 

During the year ended April 30, 2023, the Company issued 1,023,626 shares of common stock in the conversion of $76,711 convertible notes and accrued interest.

 

During the year ended April 30, 2023, the Company issued 53,750 shares of series B preferred with a value of $322,500 for the payment of note of $300,000 and interest of $22,500.

 

As of April 30, 2023, and April 30, 2022, the convertible debt outstanding, net of discount, was $319,767 and $305,127, respectively.

 

During the years ended April 30, 2023 and 2022, we had the following activity in our derivative liabilities:

 

Balance at April 30, 2021

910,511

 

 

Issuance and conversion of convertible debt, net

(113,092)

 

 

Gain on derivative liability

(492,187)

 

 

Balance at April 30, 2022

305,232

 

 

Issuance and conversion of convertible debt, net

(73,900)

 

 

Gain on derivative liability

(165,506)

 

 

Balance at April 30, 2023

  65,826

 


F-15


The estimated fair value of the derivative liabilities at April 30, 2023 and 2022 were calculated using the American Binomial pricing model with the following assumptions:

 

 

2023

2022

Risk-free interest rate

4.74%

.25%

Expected life in years

0.10

0.25-0.96

Dividend yield

0%

0%

Expected volatility

318.00%

222.00%

 

NOTE 7 - EQUITY

 

Preferred Stock

 

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A, a Series B and a series C preferred stock and a series D preferred stock. The Company has authorized 5, 000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share.  Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors.

 

During the year ended April 30, 2019, the Company converted 200,000 shares of Series A preferred into 4,000 shares of common stock.

 

On May 9, 2019, DTII’s Board of Directors unanimously resolved to revise the terms of the company’s Series A and Series B Preferred Shares. Under the new terms, the conversion right of both Series A and B Preferred Shares was changed from five (5) shares of DTII common stock for each one (1) share of Preferred Stock, to a new conversion right of ten (10) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms apply to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock. The Board received the unanimous consent to the changed terms from each current Preferred shareholder.

 

On May 20, 2019, the Company approved the issuance of 5,663 shares of its common stock for the conversion of 283,135 for Series A preferred with a value of $28. As of April 30, 2022, the Common shares had not been issued and the conversion was not completed.

 

During the year ended April 30, 2022, the Company converted 456,605 shares of series C preferred into 265,241 shares of common stock with a value of $470,981.

 

On March 10, 2022 the Company issued 657,895 shares of series A preferred for the payment of $25,000 of convertible debt.  On April 9, 2023, the Company cancelled the 657,895 shares of series A preferred and issued 657,895 of series B preferred to replace the cancelled A shares.

 

During the year ended April 30, 2022 the Company issued 600 shares of series D convertible preferred, with a value of $600,000 for the conversion of $563,318 of convertible debt and accrued interest plus the calculation of warrants outstanding to Ionic Ventures. The preferred shares are convertible into common shares at the lower of $0.50 per share or 80% of the lowest trading price 20 days prior to conversion.

 

During the year ended April 30, 2023, the Company issued 731,995 shares of series B preferred for the reduction of $2,901,836 of notes payable and accrued expenses. The issuance consisted of 279,026 shares to related parties for accrued expense of $1,074,250, 53,750 shares for the payment of $322,500 of notes payable and interest and 399,219 shares for the payment of $1,505,118 of accounts payable and accrued expenses.


F-16


 

The Company realized a loss on settlement of debt and accruals of $849,329 from the issuance of the series B preferred during the year ended April 30, 2023. The fair value of the shares issued were determined by the closing price of the number of common shares to be issued at the conversion of 10 common shares for each series B preferred share.

 

During the year ended April 30, 2023 the Company issued 25,000 shares of series B preferred for $294,998 for service.  

 

As of April 30, 2023 the Company had 2,925,369 shares of Series A, 1,913,655 Series B shares and 592 shares of series D preferred shares issued and outstanding.

 

Common Stock:

 

The Company has 400,000,000 shares of $0.0001 par value common stock authorized.  During the year ended April 30, 2022 the Company completed a reverse split of one share for each 500 shares. The presentation of the common shares are retroactive in the number of shares outstanding for both 2022 and 2021. The reverse resulted in a decrease in common stock and an increase in paid in capital.

 

During the year ended April 30, 2022 the Company issued 41,551 shares of common stock for the conversion of $132,728 of convertible debt and accrued interest.

 

During the year ended April 30, 2022 the Company issued 265,241 shares of common stock for the conversion of 450,700 series C preferred shares with a value of $469,579.

 

During the year ended April 30, 2023, the Company issued 1,023,626 shares of common stock for the conversion of $76,711 of convertible debt.

 

During the year ended April 30, 2023, the Company issued 292,119 shares of common stock for the conversion of 21,235 Series B preferred shares.

 

During the year ended April 30, 2023, the Company issued 79,766 shares of common stock for the conversion of 8 Series D preferred shares.

 

NOTE 8 – WARRANTS AND OPTIONS

 

During the year ended April 30, 2019 the Company issued 1,200 warrants with a conversion price of $350 to $1,250 to four individuals and 500 options with a conversion price of $500 to one individual. The warrants have a three year term and are convertible into the common shares of the Company.

 

Of the 1,200 warrants issued; the Company issued 800 warrants to Ionic Ventures as part of the convertible notes. The warrants contained an antidilution and reset provision to adjust to futures shares issued at a conversion price lower than the initial conversion price of $350. Along with the reset provision the length of maturity of the warrants was extended. Based on the reset provisions the number of warrants increased to 66,667 with a reset conversion price of $4.20 resulting in a down round amount of $903,270 during the year ended April 30, 2020.

 

During the year ended April 30, 2022 the issuance of shares at a strike price lower than the previous period triggered a recalculation of the number of warrants to be issued. The issuance of warrants increased by 133,213. The down round calculation on the warrants did not trigger an amount greater than the down round calculated in earlier quarters. As part of the changes, the warrants expiration dates were extended to October 30, 2023 and February 27, 2024.

 


F-17


On April 29, 2022 the Company issued 600 series D preferred shares with a value of $600,000 to Ionic Ventures in exchange for the convertible debt interest and the cancellation of all warrants outstanding. As of April 30, 2022 and 2023 there were zero warrants outstanding.

 

A summary of the Company’s stock options and warrants as of April 30, 2023, and changes during the two years then ended is as follows:

 

 

Options and

Warrants

Weighted

Average

Exercise Price

Weighted Average

Remaining

Contract Term

(Years)

Aggregate

Intrinsic

Value

 

 

 

 

 

 

Outstanding and exercisable at April 30, 2021

38,367

 

14.30

2.48

$ 239,861

Granted by adjustment

133,213

 

1.40

2.31

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

(1,580)

 

--

--

--

Exchanged for preferred shares

(200,000)

 

--

--

--

Outstanding and excisable at April 30, 2022

--

 

--

--

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

--

 

--

--

--

Outstanding and exercisable at April 30, 2023

--

 

--

--

--

 

NOTE 9 – INCOME TAX

 

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by the valuation allowances when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

The Company’s deferred tax assets for the Company consisted of the following as of April 30, 2023 and 2022:

 

 

2023

 

2022

 

 

 

 

 

Income/(Loss) Before Income Taxes

$

(2,627,563)

$

(718,325)

Taxable income(loss)

 

(2,462,057)

 

(242,327)

Valuation Allowance

 

 

 

1,069,501

Net Operating Losses

 

(7,554,918)

 

(5,092,861)

Tax Rate

 

21%

 

21%

 

 

 

 

 

Deferred Tax Assets

 

(1,586,533)

 

(1,069,501)

Valuation Allowance

 

1,586,533

 

1,069,501

Net Deferred Tax Assets

$

--

$

--

 


F-18


The Company had a net loss of for the years ended April 30, 2023 and 2022, respectively. As of April 30, 2023, the Company had a net operating loss carry forward of $7,554,918 which can be used to offset future taxable income.  

 

A reconciliation of income taxes at the federal statutory rate to amounts provided for the years ended April 30, 2023 and 2022 as follows:

 

2023

 

2022

 U.S. federal statutory rate

21%

 

21%

 Net operating loss

(21%)

 

(21%)

Effective tax rate

--%

 

--%

 

The Company’s tax years within the United States remain open for review back to 2016.

 

The Company’s policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

The Company has the following commitments as of April 30, 2023:

 

a)  

Administration Agreement with EMAC Handels AG, renewed effective May 1, 2014 for a period of three years. Monthly fee for administration services of $7,500 office rent of $250 and office supplies of $125.  Extraordinary expenses are invoiced by EMAC on a quarterly basis.  The fee may be paid in cash and or with common stock.

 

b)  

Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company.  The fees may be paid in cash and or with common stock.

 

c)  

Service Agreement signed May 20, 2016 with Charles C. Hooper, Director, for services of $5,000 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company.  The fees may be paid in cash and or with common stock.

 

d)  

Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handels AG, for general fees of $5,000 per month, office rent of $250 and telephone of $125 beginning January 2017, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales.

 

e)  

Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI.  

 

f)  

Business Development and Consulting Agreement of PSSI signed January 15, 2017 with WSMG Advisors, Inc., for finder’s fees of 10% of funding raised for PSSI and the issuance of 1,000 common shares of PSSI.  


F-19


 

NOTE 11 – SUBSEQUENT EVENTS

 

During the period from May 1 to the date of filing the Company issued 569,681 shares of common stock with a value of $14,686 for the conversion of convertible debt.

 

During the period from May 1 to the date of filing the Company issued 115,955 shares of common stock with a value of $3,188 for the conversion of three series D convertible preferred shares.

 

During the period from May 1 to the date of filing the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

 

The Company has evaluated subsequent events to determine events occurring after April 30, 2023 through the date of this report that would have a material impact on the Company’s financial results or require disclosure and have determined none exist.

 

 


F-20

 

Exhibit 21.1

 

SUBSIDIARIES OF DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

 

 

Name of Subsidiary

Jurisdiction of Organization

 

 

Passive Security Scan Inc.

Utah

(Majority owned subsidiary of

 

Defense Technologies International Corp.)

 


Exhibit 31.1 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Merrill W. Moses, certify that: 

 

1.I have reviewed this annual report on Form 10-K of Defense Technologies International Corp.  

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

 

Date:August 25, 2023 

 

/S/   MERRILL W. MOSES

 

Merrill W. Moses

Chief Executive Officer

Interim Chief Financial Officer

(Acting Principal Accounting Officer)


Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of Defense Technologies International Corp (the “Company”) on Form 10-K for the period ended April 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Merrill W. Moses, Chief Executive Officer and Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that: 

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. 

 

 

/s/   MERRILL W. MOSES

 

Merrill W. Moses

Chief Executive Officer

Interim Chief Financial Officer

(Acting Principal Accounting Officer)

August 25, 2023

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.  The foregoing certifications are accompanying the Company's Form 10-K solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.


v3.23.2
Document and Entity Information - USD ($)
12 Months Ended
Apr. 30, 2023
Aug. 25, 2023
Oct. 31, 2022
Details      
Registrant CIK 0001533357    
Fiscal Year End --04-30    
Registrant Name DEFENSE TECHNOLOGIES INTERNATIONAL CORP.    
SEC Form 10-K/A    
Period End date Apr. 30, 2023    
Tax Identification Number (TIN) 99-0363802    
Number of common stock shares outstanding   2,488,678  
Public Float     $ 194,068
Filer Category Non-accelerated Filer    
Current with reporting Yes    
Interactive Data Current Yes    
Voluntary filer No    
Well-known Seasoned Issuer No    
Shell Company false    
Small Business true    
Emerging Growth Company false    
Document Financial Statement Error Correction false    
Amendment Description A draft of the Company 10-K was incorrectly filed on August 15, 2023 without approval. It should not be relied on as the audited financials of the Company. The amended copy being filed herein accurately reflects the Company's financial conditions as of April 30, 2023.    
Document Annual Report true    
Document Transition Report false    
Entity File Number 000-54851    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 2683 Via De La Valle    
Entity Address, Address Line Two Suite G418    
Entity Address, City or Town Del Mar    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92014    
City Area Code 800    
Local Phone Number 520-9485    
Amendment Flag true    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Auditor Name Fruci & Associates II, PLLC    
Auditor Firm ID 5525    
Auditor Location Spokane, Washington    
v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Apr. 30, 2023
Apr. 30, 2022
Current assets    
Cash $ 804 $ 5,761
Inventory 34,512 69,649
Total current assets 35,316 75,407
Fixed assets , net of depreciation of $34,911 and $26,235 0 8,676
Total assets 35,316 84,083
Current liabilities    
Accounts payable and accrued expenses 260,765 700,921
Accrued license agreement payment 37,500 171,300
Accrued interest and fees payable 150,517 147,877
Customer deposits 30,375 30,375
Derivative liabilities 65,826 305,232
Convertible notes payable, net of discount 319,767 305,127
Payables - related parties 910,524 1,554,639
Notes payable 64,092 375,042
Notes payable- related party 115,600 0
Total current liabilities 1,954,966 3,590,513
Total liabilities 1,954,966 3,590,513
Commitments and contingencies 0 0
Stockholders' deficit    
Common shares 181 49
Additional paid-in capital 14,905,851 10,657,067
Accumulated deficit (16,527,130) (13,916,844)
Total (1,620,615) (3,259,318)
Non-controlling interest (299,035) (247,112)
Total stockholders' deficit (1,919,650) (3,506,430)
Total liabilities and stockholders' deficit 35,316 84,083
Series A Preferred Stock    
Stockholders' deficit    
Preferred shares 292 358
Series B Preferred Stock    
Stockholders' deficit    
Preferred shares $ 191 $ 52
v3.23.2
Condensed Consolidated Balance Sheets - Parenthetical - USD ($)
Apr. 30, 2023
Apr. 30, 2022
Fixed Assets, Depreciation $ 34,911 $ 26,235
Preferred Stock, Par or Stated Value Per Share $ 0.0001  
Preferred Stock, Shares Authorized 20,000,000  
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 600,000,000 600,000,000
Common Stock, Shares, Issued 1,803,042 487,408
Common Stock, Shares, Outstanding 1,803,042 487,408
Series A Preferred Stock    
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 20,000,000 20,000,000
Preferred Stock, Shares Issued 2,925,369 3,583,264
Preferred Stock, Shares Outstanding 2,925,369 3,583,264
Series B Preferred Stock    
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 20,000,000 20,000,000
Preferred Stock, Shares Issued 1,913,655 520,000
Preferred Stock, Shares Outstanding 1,913,655 520,000
v3.23.2
Condensed Consolidated Statement of Operations - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Condensed Consolidated Statement of Operations    
Revenue $ 0 $ 0
Cost of goods 0 0
Operating expenses    
Consulting fees 1,180,900 495,000
Depreciation 8,675 11,660
Development 259,243 0
General and administrative 285,297 360,937
Total operating expenses 1,734,115 867,597
Loss from operations (1,734,115) (743,128)
Other income (expense)    
Loss on stock issuance 0 (65,007)
Gain (loss) on notes payable 0 (21,610)
Finance and interest cost on notes 0 (7,500)
Impairment of asset (40,586) 0
Inventory adjustment (5,397) (8,728)
Interest expense including penalty and debt discount (163,643) (203,388)
Gain (loss) on derivative liabilities 165,506 492,187
Gain (loss) on extinguishment of debt (849,329) (36,682)
Total other income (expense) (893,449) 149,272
Gain(loss) before income taxes (2,627,564) (718,325)
Provision for income taxes 0 0
Net gain (loss) (2,627,564) (718,325)
Non-controlling interest in net loss of consolidated subsidiary 51,923 42,701
Net gain (loss) attributed to the Company $ (2,575,641) $ (675,624)
Net loss per common share - basic and diluted $ (384.74) $ (2.25)
Weighted average shares outstanding - basic and diluted 670,681 299,712
v3.23.2
Consolidated Statements of Shareholders' Deficit - USD ($)
Additional Paid-in Capital
Total
Preferred Stock
Common Stock
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Apr. 30, 2021     $ 344 $ 18
Shares, Outstanding, Beginning Balance at Apr. 30, 2021     3,690,069 180,485
Common stock issued for conversion of debt, Value     $ 0 $ 4
Common stock issued for preferred shares, Value     $ 0 $ 27
Common stock issued for preferred shares, Shares     (450,700) 265,241
Rounding of shares issued     $ 0 $ 0
Rounding of shares issued, shares       131
Temporary equity - Preferred shares, Stock     206,000  
Retirement of derivative at conversion   $ 211,103 $ 0 $ 0
Net income (loss) before non-controlling interest   (718,325) 0 0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Apr. 30, 2022   (3,506,430) $ 410 $ 49
Shares, Outstanding, Ending Balance at Apr. 30, 2022     4,103,864 487,408
Common stock issued for conversion of debt shares       41,551
Temporary equity- Preferred shares issued for cash     $ 0 $ 0
Temporary equity- preferred shares issued for debt     $ 0 0
Temporary equity- preferred shares issued for debt Share     600  
Deemed dividend on preferred shares     $ 0 0
Preferred shares issued for convertible debt     $ 7 0
Preferred shares issued for convertible debt Share     657,895  
Shares issued for service   0    
Gain (loss) on extinguishment of debt   36,682    
Deemed dividend on preferred shares     $ 0 0
Common stock issued for conversion of debt, Value     0 102
Retirement of derivative at conversion   73,900 0 0
Net income (loss) before non-controlling interest   (2,627,564) 0 0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Apr. 30, 2023   (1,919,650) $ 483 $ 181
Shares, Outstanding, Ending Balance at Apr. 30, 2023     4,839,616 1,803,042
Common stock issued for conversion of debt shares       1,023,626
Deemed dividend on preferred shares     $ 0 $ 0
Common stock issued for preferred shares conversion     $ 0 $ 29
Common stock issued for preferred shares conversion     (21,235) 212,353
Preferred shares issued to related parties   1,074,250 $ 28 $ 0
Preferred shares issued to related parties     279,026  
Preferred shares issued for accrued expense $ 1,505,118   $ 39 0
Preferred shares issued for accrued expense     399,219  
Shares issued for service   294,998 $ 2 0
Shares issued for service     25,000  
Preferred shares reclassified to equity     $ 0 $ 1
Preferred shares reclassified to equity       0
Preferred shares for notes payable   322,500 $ 4 $ 0
Preferred shares for notes payable     53,750  
Common stock issued for conversion of D shares     $ 0 $ 0
Common stock issued for conversion of D shares     (8) 79,766
Gain (loss) on extinguishment of debt   $ 849,329 $ 0 $ 0
Deemed dividend on preferred shares     0 0
Common shares returned     $ 0 $ 0
Common shares returned       (111)
v3.23.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Cash flows from operating activities    
Net income (loss) before non-controlling interest $ (2,627,564) $ (718,325)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation 8,676 11,660
Shares issued for service 294,998 0
Amortization of debt discount and financing fees 91,350 96,160
(Gain) loss on derivative liabilities (165,506) (492,187)
(Gain) loss on extinguishment of debt 0 36,682
Gain (loss) on issuance of convertible notes 0 (21,610)
Loss on stock issuance 849,329 65,007
Change in operating assets and liabilities    
(Increase) decrease in inventory 35,134 (265)
Increase in accounts payable and accrued expense 973,841 412,842
Prepaid 0 20,000
Increase in payables - related parties 430,135 304,821
Net cash used in operating activities (109,607) (285,215)
Net Cash Provided by (Used in) Investing Activities    
Temporary equity from preferred shares for cash 0 177,500
Proceeds from notes payable- related party 134,650 0
Proceeds from convertible notes payable, net 0 75,000
Proceeds (repayment) from notes payable (30,000) (5,733)
Net Cash Provided by (Used in) Financing Activities 104,650 246,767
Net increase (decrease) in cash (4,957) (38,448)
Cash at beginning of the year 5,761 44,209
Cash at end of the year 804 5,761
Supplemental Cash Flow Information    
Interest paid 0 0
Income tax paid 0 0
Non-Monetary Transactions    
Interest accrued on preferred shares 34,645 12,217
Common stock issued for convertible debt 76,711 132,728
Common stock issued for conversion of preferred shares 0 470,982
Retirement of derivative at conversion 73,900 211,103
Derivative liabilities for day 1 on tainted convertible notes 0 90,656
Preferred shares issued for convertible debt 322,499 563,318
Preferred shares issued for payment of debt 1,505,157 25,000
Preferred shares issued for accrued liabilities - related party $ 1,074,250 $ 0
v3.23.2
Note 1 - Nature of Operations and Continuation of Business
12 Months Ended
Apr. 30, 2023
Notes  
Note 1 - Nature of Operations and Continuation of Business

NOTE 1 - NATURE OF BUSINESS AND CONTINUED OPERATIONS

 

Defense Technologies International Corp. (the "Company ") was incorporated in the State of Delaware on May 27, 1998.  Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to represent the Company’s expansion goals more fully into the advanced technology sector.

 

Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.

 

On January 19, 2018, the Board of Directors, with the approval of a majority of the shareholders, passed a resolution to affect a reverse split of the Company’s outstanding common stock on a 1 share for 1,500 shares (1:1500) basis. The reverse split was effective on March 20, 2018. The number of shares in the financials are reflective of the reverse split.  

 

On June 28, 2022, the Company received approval for a reverse split of its common shares of 1:500. As a result of the reverse split all common shares in the 10-K are restated with the number of shares effected by the reverse.

 

Going Concern

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern.  Through April 30, 2023, the Company had no revenue, has accumulated deficit of $16,527,130 and a working capital deficit of $1,919,650 and expects to incur further losses in the development of its business, all of which cast substantial doubt about the Company’s ability to continue as a going concern.  Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2023 by issuing debt and equity securities and by the continued support of its related parties.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.  There is no assurance that funding will be available to continue the Company’s business operations.

v3.23.2
Note 2 - Summary of Significant Accounting Policies
12 Months Ended
Apr. 30, 2023
Notes  
Note 2 - Summary of Significant Accounting Policies

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.  The Company’s fiscal year end is April 30.  

 

Recent Accounting Pronouncements

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by

removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas.  The ASU is effective for annual and interim periods beginning after December 31, 2021 and early adoption is permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company has evaluated the impact that this new guidance will have on its financial statements and concluded there will be no change.

 

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or results of operations.

 

Consolidation and Non-Controlling Interest

 

These consolidated financial statements include the accounts of the Company, and its wholly owned subsidiary, Long Canyon, through January 15, 2017, and its majority-owned subsidiary, PSSI, from its formation on January 15, 2017.  All inter-company transactions and balances have been eliminated.

 

The non-controlling interest in PSSI, representing 10,883 common shares, or 23.72%, was acquired by several individuals and entities, including related parties, in exchange for services valued at $6,100 and the extinguishment of Company accounts payable – related parties with a book value of $9,835.

 

Reclassification

 

The Company is reclassing the equity section of the consolidated balance sheet for the year ended April 30, 2022, due to a reclassification of series D preferred from mezzanine equity to equity. Initially, the 600 shares of series D preferred were presented in mezzanine equity. The reclassification reduces the mezzanine equity from 600,000 to zero and increase paid in capital to 600,000. Although the series D preferred were in the settlement of convertible notes, and the convertible into common stock, the conversion feature is not set and at the election of the board of directors. The Company also reclassed series A preferred shares increasing the preferred A shares by 59 reducing paid in capital by the same amount. The impact of the reclassification effect only balance sheet presented as of April 30, 2022.

 

Impairment of Inventory

 

The Company reviews the carrying value of its assets annually or whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the asset. The Company determined although their inventory is salable, none has been sold for over 2 years, but there is a potential of obsolescence to the asset. This could occur due to refinement of the finished product or enhancement of the parts used in the product.  The Company has determined that some impairment has occurred and is reserving an impairment. As of April 30, 2023, the Company reserved $40,586 as an impairment of the value of the inventory.

 

Basic and Diluted Net Loss per Share

 

The Company computes net loss per share in accordance with ASC 260, Earnings per Share, which requires presentation of both basic and diluted loss per share (“EPS”) on the face of the statement of operations.  Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted

average number of common shares outstanding (denominator) during the period.  Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, convertible preferred stock, and convertible debt, using the if-converted method.  In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all potentially dilutive common shares if their effect is antidilutive.  

 

As of April 30, 2023, convertible debt and related accrued interest payable plus conversion of A, B and D preferred shares are convertible into 48,924,638 shares of the Company’s common stock.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes.  The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse.  The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.  The actual results experienced by the Company may differ materially and adversely from the Company’s estimates.  To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Financial Instruments

 

Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value using a hierarchy based on the level of independent, objective evidence when measuring fair value using a hierarch based on the level of independent, objective evidence surrounding the inputs used to measure fair value.  A financial instrument’s categorization with the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy prioritized the inputs into three levels that may be used to measure fair value:

 

Level 1:  applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2:  applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in markets that are not active.

 

Level 3:  applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

As of April 30, 2023 and 2022, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.

 

Liabilities measured at fair value on a recurring basis were estimated as follows at April 30, 2023 and 2022:

 

Total

Level 1

Level 2

Level 3

2022

 

 

 

 

Derivative liabilities

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$     305,232

$          --

$          --

 $  305,232

 

 

 

 

 

2023

 

 

 

 

Derivate liabilities

$   65,826

$          --

$          --

$    65,826

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$   65,826

$          --

$          --

$   65,826

 

Derivative Liabilities

 

We have identified the conversion features of certain of our convertible notes payable as derivatives.  We estimate the fair value of the derivatives using the Black-Scholes pricing model.  We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, and a gain or loss on change in derivative liabilities as applicable.  These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility and variable conversion prices based on market prices as defined in the respective agreements.  These inputs are subject to significant changes from period to period and to management's judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

 

Non-Monetary Transactions

 

All issuances of the Company’s common stock for non-cash consideration have been assigned a dollar amount equaling either the market value of the shares issued, or the value of consideration received whichever is more readily determinable.  The majority of the non-cash consideration received pertains to services rendered by consultants and others and has been valued at the market value of the shares issued.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and consultants in accordance with FASB ASC 718. Stock-based compensation to employees is measured at the grant date, based on the fair value of the award, and is recognized as expense over the requisite employee service period. The Company estimates the fair value of stock-based payments using the Black Scholes option-pricing model for common stock options and warrants and the closing price of the Company’s common stock for common share issuances.

 

Cash and Cash Equivalents

 

The Company considers all investments purchased with original maturity of three or fewer months to be cash equivalents.

 

 

Inventory

 

Inventories are stated at the lower or cost of market using the first-in; first-out (FIFO) cost method of accounting. The inventory consists of raw materials used to make products, work in progress of zero and finished goods for sale with a total value of inventory after impairment of $34,512.

 

Equipment

 

Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets which is 36 months. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.

v3.23.2
Note 3 - License Agreement
12 Months Ended
Apr. 30, 2023
Notes  
Note 3 - License Agreement

NOTE 3 – LICENSE AGREEMENT

 

Effective July 15, 2016, the Company executed documents intended to finalize the acquisition of 100% of Defense Technology Corporation, a non-related privately held Colorado company ("DTC"), a developer of defense, detection and protection products to improve security for Anchor schools and other public facilities.  Subsequently, the Company and DTC mutually agreed to rescind the acquisition of DTC and entered into a Rescission Agreement and Mutual Release (the "Rescission Agreement"), dated October 17, 2016.

 

In connection with the Rescission Agreement with the Company, DTC rescinded its agreement with the inventor and developer of the technology and assets that were subject to the original agreement between the Company and DTC.  On October 19, 2016, the Company entered into a new Definitive Agreement with Controlled Capture Systems, LLC ("CCS"), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement.  Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements.  The term of the License Agreement will be from October 19, 2016 until the expiration of the last to expire of the licensed issued patents or patents to be issued.

 

The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties at the end of each six-month period at the rate of the greater of 5% of gross sales used or sold, or the minimum royalty payment of $25,000.  The Company also agreed to compensate investors that have provided funding for the development of CCS's technology with 5 shares of the Company's common stock.  Additionally, CCS will be entitled to receive 1 shares of the Company's common stock upon completed sales of 1,000 passive scanner units based on the CCS technology.

 

The Independent Contractor Agreement between the Company and CCS provides that CCS will provide support for the development of the security technology and products.  An initial payment of $5,000 was paid to CCS plus ongoing hourly compensation for services provided.

 

The Company capitalized the costs to acquire the License Agreement, including the $25,000 initial licensing fee and the estimated value of $353,600 of the 5 shares of the Company's common stock issued on November 10, 2016 to the CCS investors, which value was based on the closing market price of the Company's common stock on the date of the Definitive Agreement. The Company has recorded a current liability of $37,500 in its consolidated balance sheet as of April 30, 2023 and $171,300 as of April 30, 2022. The decrease in amount owed from year 2023 to 2022 is due to the conversion of debt to preferred shares during the fiscal year ended April 30, 2023. Once sales of products based on the CCS technology begin, the Company will amortize the capitalized costs over the estimated life of the license agreement as determined by the legal life of patents issued.

 

On January 15, 2017, the Company transferred the License Agreement to PSSI in exchange for 15,000,000 common shares of PSSI, or 65.38% ownership. During the FY 2018 the Company increased its ownership of PSSI to 17,500,000 shares or 76.28% of the Company. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.

 

On January 22, 2017, the Company and CCS entered into an Amendment to the Definitive Agreement, whereby CCS consented to the transfer of the Definitive Agreement, Patent License Agreement, and Independent Contractor Agreement to PSSI and agreed to extend the due dates of certain payments due CCS to April 30, 2017. In exchange, CCS received 100,000 shares of PSSI common stock.

 

Also, in connection with the Amendment to the Definitive Agreement, the investors that provided funding for the development of CCS's technology received 500,000 shares of PSSI common stock.

 

The Company reviewed its valuation of the license agreement and as of April 30, 2019 the Company elected to fully impair its licenses agreement resulting in an impairment loss of $378,600.

v3.23.2
Note 4 - Related Party Transactions and Balances
12 Months Ended
Apr. 30, 2023
Notes  
Note 4 - Related Party Transactions and Balances

NOTE 4 - RELATED PARTY TRANSACTIONS

 

Payables – Related Parties

 

During the years ended April 30, 2023 and 2022, management and administrative services were compensated by the Company pursuant to: a Service Agreement between the Company and Merrill Moses, President, CEO, Secretary, acting CFO and director, dated April 25, 2016; a Service Agreement between the Company and Charles Hooper, director, dated May 20, 2016; and an Administration Agreement with EMAC Handles AG (“EMAC”), a shareholder of the Company and PSSI, executed on March 15, 2011 and renewed on May 1, 2014.  

 

During the year ended April 30, 2022, management and administrative services were compensated by PSSI pursuant to a Service Agreement between PSSI and Merrill Moses, dated January 12, 2017 and effective February 1, 2017 and an Administration and Management Agreement dated January 12, 2017 between PSSI and RAB Investments AG (“RAB”), a significant lender of the Company and a shareholder of PSSI.

 

The fees are based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with the Company’s common stock.  The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay.  These types of transactions, when incurred, result in payables to related parties in the Company's consolidated financial statements as a necessary part of funding the Company's operations.

 

Previously on December 11, 2018, the Board of Directors resolved to change the terms of the company’s Series A and Series B Preferred Shares from ten (10) shares of DTII common stock for each one (1) share of Preferred Stock, to five (5) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms applied to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock.

 

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $115,600 plus accrued interest.

 

During the year ended April 30, 2023, the Company entered into a loan agreement with Star Anchor, a related party, for short term loans. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $19,050 plus accrued interest.

 

During the year ended April 30, 2023, the Company issued 279,026 series B preferred shares to three related parties for the payment of $1,074,250 of accrued expenses.

 

As of April 30, 2023 and 2022, the Company had payable balances due to related parties totaling $910,524 and $1,554,639, respectively, which resulted from transactions with shareholders, officers and directors of the Company.

v3.23.2
Note 5 - Notes Payable
12 Months Ended
Apr. 30, 2023
Notes  
Note 5 - Notes Payable

NOTE 5 - NOTES PAYABLE

 

On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment fund generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

 

On July 6, 2018, the Company signed an investment agreement with a third party. Under the terms of the agreement the Company receive $250,000 through the Company attorney’s trust account. On July 12, 2018, the Company received the $250,000 less wire and legal payment of $10,045. In addition, the note holder will receive a royalty of 5% up to $250,000 and then a royalty of 3.5% for two years thereafter. The noteholder will receive 300 shares of the Company’s common stock plus 200 warrants to purchase common shares within three years at $1,250 per share.  As of April 30, 2023, the warrants had expired. On July 29, 2022, the Company issued 53,750 shares of series B preferred for the outstanding principal of $300,000 and interest of $22,500 leaving the balance due at zero.

 

On July 18, 2018, the Company entered into a promissory note of $114,226.26 with interest rate of 8% per annum with Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is to pay Haynie $5,000 per month. In addition, the Company shall pay the noteholder 20% of any funding event of private or public equity. As of April 30, 2023 the Company owed the note holder $20,042 plus interest. As of April 30, 2023 the note is in default.

 

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum.  As of January 31, 2023, the outstanding balance on the loan agreement was $115,600 plus accrued interest.

 

During the year ended April 30, 2023, the Company entered into a loan agreement with Star Anchor for short term loans. The loans bear interest at 6% per annum. As of April 30, 2023, the outstanding balance on the loan agreement was $19,050 plus accrued interest.

 

As of April 30, 2023 and 2022, the outstanding balances of notes payable was $175,692 and $375,042, respectively.

v3.23.2
Note 6 - Convertible Debt
12 Months Ended
Apr. 30, 2023
Notes  
Note 6 - Convertible Debt

NOTE 6 - CONVERTIBLE DEBT

 

On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $25 per share.  The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of April 30, 2023 the balance of the notes was $7,000 plus interest.

 

On February 16, 2018 Passive Security Scan Inc, a subsidiary of the Company issued a $20,000 convertible note to Stuart Young. The note bears interest at 6% and is convertible after 6 months from the date of the note into stock of either PSSI or the Company at 50% discount to the 10 day trailing trading value of the Company’s common stock.  

 

On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment fund generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

 

On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $330,626 which included the additional interest and retired the original notes. The Company issued shares of series A preferred with a value of $ 25,000 for payment against the convertible note.  On April 28, 2023 the Company issued 145,000 shares of common stock with a value of $7,250 for payment against the note.  As of April 30, 2023, the outstanding balance of the notes were $278,376 plus interest.

 

On January 13, 2020, the Company issued an additional note to Ionic Ventures, LLC for $220,000 with an original discount of $20,000.  The note is part of a securities purchase agreement dated August 31, 2018. The note matures on June 20, 2020 bearing interest at the rate of 15% per annum. The note is convertible into common stock of the Company at $300 per share or of 60% of the lowest trading price for twenty days prior to conversion, whichever is the lowest.  The note and all subsequent notes from Ionic contain reset provisions.  Based on the reset provision the conversion price as of April 30, 2021 was $4.20 per share.  An additional $5,000 was added to the note for note extension leaving the balance as of April 30, 2021 of $225,000. On April 29, 2022 the Company issued 600 shares of series D convertible preferred with a value of $600,000 for the payment of $563,318 of convertible debt and accrued interest plus the calculation of warrants outstanding to Ionic Ventures cancelling both notes to Ionic Ventures.  As a result of this transaction the Company incurred a loss on settlement of debt of $36,682.

 

During the year ended April 30, 2022, the Company issued 41,551 shares of common stock in the conversion of $132,728 convertible notes and accrued interest.

 

During the year ended April 30, 2023, the Company issued 1,023,626 shares of common stock in the conversion of $76,711 convertible notes and accrued interest.

 

During the year ended April 30, 2023, the Company issued 53,750 shares of series B preferred with a value of $322,500 for the payment of note of $300,000 and interest of $22,500.

 

As of April 30, 2023, and April 30, 2022, the convertible debt outstanding, net of discount, was $319,767 and $305,127, respectively.

 

During the years ended April 30, 2023 and 2022, we had the following activity in our derivative liabilities:

 

Balance at April 30, 2021

910,511

 

 

Issuance and conversion of convertible debt, net

(113,092)

 

 

Gain on derivative liability

(492,187)

 

 

Balance at April 30, 2022

305,232

 

 

Issuance and conversion of convertible debt, net

(73,900)

 

 

Gain on derivative liability

(165,506)

 

 

Balance at April 30, 2023

  65,826

 

The estimated fair value of the derivative liabilities at April 30, 2023 and 2022 were calculated using the American Binomial pricing model with the following assumptions:

 

 

2023

2022

Risk-free interest rate

4.74%

.25%

Expected life in years

0.10

0.25-0.96

Dividend yield

0%

0%

Expected volatility

318.00%

222.00%

v3.23.2
Note 7 - Equity
12 Months Ended
Apr. 30, 2023
Notes  
Note 7 - Equity

NOTE 7 - EQUITY

 

Preferred Stock

 

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A, a Series B and a series C preferred stock and a series D preferred stock. The Company has authorized 5, 000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share.  Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors.

 

During the year ended April 30, 2019, the Company converted 200,000 shares of Series A preferred into 4,000 shares of common stock.

 

On May 9, 2019, DTII’s Board of Directors unanimously resolved to revise the terms of the company’s Series A and Series B Preferred Shares. Under the new terms, the conversion right of both Series A and B Preferred Shares was changed from five (5) shares of DTII common stock for each one (1) share of Preferred Stock, to a new conversion right of ten (10) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms apply to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock. The Board received the unanimous consent to the changed terms from each current Preferred shareholder.

 

On May 20, 2019, the Company approved the issuance of 5,663 shares of its common stock for the conversion of 283,135 for Series A preferred with a value of $28. As of April 30, 2022, the Common shares had not been issued and the conversion was not completed.

 

During the year ended April 30, 2022, the Company converted 456,605 shares of series C preferred into 265,241 shares of common stock with a value of $470,981.

 

On March 10, 2022 the Company issued 657,895 shares of series A preferred for the payment of $25,000 of convertible debt.  On April 9, 2023, the Company cancelled the 657,895 shares of series A preferred and issued 657,895 of series B preferred to replace the cancelled A shares.

 

During the year ended April 30, 2022 the Company issued 600 shares of series D convertible preferred, with a value of $600,000 for the conversion of $563,318 of convertible debt and accrued interest plus the calculation of warrants outstanding to Ionic Ventures. The preferred shares are convertible into common shares at the lower of $0.50 per share or 80% of the lowest trading price 20 days prior to conversion.

 

During the year ended April 30, 2023, the Company issued 731,995 shares of series B preferred for the reduction of $2,901,836 of notes payable and accrued expenses. The issuance consisted of 279,026 shares to related parties for accrued expense of $1,074,250, 53,750 shares for the payment of $322,500 of notes payable and interest and 399,219 shares for the payment of $1,505,118 of accounts payable and accrued expenses.

 

The Company realized a loss on settlement of debt and accruals of $849,329 from the issuance of the series B preferred during the year ended April 30, 2023. The fair value of the shares issued were determined by the closing price of the number of common shares to be issued at the conversion of 10 common shares for each series B preferred share.

 

During the year ended April 30, 2023 the Company issued 25,000 shares of series B preferred for $294,998 for service.  

 

As of April 30, 2023 the Company had 2,925,369 shares of Series A, 1,913,655 Series B shares and 592 shares of series D preferred shares issued and outstanding.

 

Common Stock:

 

The Company has 400,000,000 shares of $0.0001 par value common stock authorized.  During the year ended April 30, 2022 the Company completed a reverse split of one share for each 500 shares. The presentation of the common shares are retroactive in the number of shares outstanding for both 2022 and 2021. The reverse resulted in a decrease in common stock and an increase in paid in capital.

 

During the year ended April 30, 2022 the Company issued 41,551 shares of common stock for the conversion of $132,728 of convertible debt and accrued interest.

 

During the year ended April 30, 2022 the Company issued 265,241 shares of common stock for the conversion of 450,700 series C preferred shares with a value of $469,579.

 

During the year ended April 30, 2023, the Company issued 1,023,626 shares of common stock for the conversion of $76,711 of convertible debt.

 

During the year ended April 30, 2023, the Company issued 292,119 shares of common stock for the conversion of 21,235 Series B preferred shares.

 

During the year ended April 30, 2023, the Company issued 79,766 shares of common stock for the conversion of 8 Series D preferred shares.

v3.23.2
Note 8 - Warrants and Options
12 Months Ended
Apr. 30, 2023
Notes  
Note 8 - Warrants and Options

NOTE 8 – WARRANTS AND OPTIONS

 

During the year ended April 30, 2019 the Company issued 1,200 warrants with a conversion price of $350 to $1,250 to four individuals and 500 options with a conversion price of $500 to one individual. The warrants have a three year term and are convertible into the common shares of the Company.

 

Of the 1,200 warrants issued; the Company issued 800 warrants to Ionic Ventures as part of the convertible notes. The warrants contained an antidilution and reset provision to adjust to futures shares issued at a conversion price lower than the initial conversion price of $350. Along with the reset provision the length of maturity of the warrants was extended. Based on the reset provisions the number of warrants increased to 66,667 with a reset conversion price of $4.20 resulting in a down round amount of $903,270 during the year ended April 30, 2020.

 

During the year ended April 30, 2022 the issuance of shares at a strike price lower than the previous period triggered a recalculation of the number of warrants to be issued. The issuance of warrants increased by 133,213. The down round calculation on the warrants did not trigger an amount greater than the down round calculated in earlier quarters. As part of the changes, the warrants expiration dates were extended to October 30, 2023 and February 27, 2024.

 

On April 29, 2022 the Company issued 600 series D preferred shares with a value of $600,000 to Ionic Ventures in exchange for the convertible debt interest and the cancellation of all warrants outstanding. As of April 30, 2022 and 2023 there were zero warrants outstanding.

 

A summary of the Company’s stock options and warrants as of April 30, 2023, and changes during the two years then ended is as follows:

 

 

Options and

Warrants

Weighted

Average

Exercise Price

Weighted Average

Remaining

Contract Term

(Years)

Aggregate

Intrinsic

Value

 

 

 

 

 

 

Outstanding and exercisable at April 30, 2021

38,367

 

14.30

2.48

$ 239,861

Granted by adjustment

133,213

 

1.40

2.31

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

(1,580)

 

--

--

--

Exchanged for preferred shares

(200,000)

 

--

--

--

Outstanding and excisable at April 30, 2022

--

 

--

--

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

--

 

--

--

--

Outstanding and exercisable at April 30, 2023

--

 

--

--

--

v3.23.2
Note 9 - Income Tax
12 Months Ended
Apr. 30, 2023
Notes  
Note 9 - Income Tax

NOTE 9 – INCOME TAX

 

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by the valuation allowances when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

The Company’s deferred tax assets for the Company consisted of the following as of April 30, 2023 and 2022:

 

 

2023

 

2022

 

 

 

 

 

Income/(Loss) Before Income Taxes

$

(2,627,563)

$

(718,325)

Taxable income(loss)

 

(2,462,057)

 

(242,327)

Valuation Allowance

 

 

 

1,069,501

Net Operating Losses

 

(7,554,918)

 

(5,092,861)

Tax Rate

 

21%

 

21%

 

 

 

 

 

Deferred Tax Assets

 

(1,586,533)

 

(1,069,501)

Valuation Allowance

 

1,586,533

 

1,069,501

Net Deferred Tax Assets

$

--

$

--

 

The Company had a net loss of for the years ended April 30, 2023 and 2022, respectively. As of April 30, 2023, the Company had a net operating loss carry forward of $7,554,918 which can be used to offset future taxable income.  

 

A reconciliation of income taxes at the federal statutory rate to amounts provided for the years ended April 30, 2023 and 2022 as follows:

 

2023

 

2022

 U.S. federal statutory rate

21%

 

21%

 Net operating loss

(21%)

 

(21%)

Effective tax rate

--%

 

--%

 

The Company’s tax years within the United States remain open for review back to 2016.

 

The Company’s policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

v3.23.2
Note 10 - Commitments and Contingencies
12 Months Ended
Apr. 30, 2023
Notes  
Note 10 - Commitments and Contingencies

NOTE 10 – COMMITMENTS AND CONTINGENCIES

 

The Company has the following commitments as of April 30, 2023:

 

a)  

Administration Agreement with EMAC Handels AG, renewed effective May 1, 2014 for a period of three years. Monthly fee for administration services of $7,500 office rent of $250 and office supplies of $125.  Extraordinary expenses are invoiced by EMAC on a quarterly basis.  The fee may be paid in cash and or with common stock.

 

b)  

Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company.  The fees may be paid in cash and or with common stock.

 

c)  

Service Agreement signed May 20, 2016 with Charles C. Hooper, Director, for services of $5,000 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company.  The fees may be paid in cash and or with common stock.

 

d)  

Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handels AG, for general fees of $5,000 per month, office rent of $250 and telephone of $125 beginning January 2017, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales.

 

e)  

Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI.  

 

f)  

Business Development and Consulting Agreement of PSSI signed January 15, 2017 with WSMG Advisors, Inc., for finder’s fees of 10% of funding raised for PSSI and the issuance of 1,000 common shares of PSSI.  

v3.23.2
Note 11 - Subsequent Events
12 Months Ended
Apr. 30, 2023
Notes  
Note 11 - Subsequent Events

NOTE 11 – SUBSEQUENT EVENTS

 

During the period from May 1 to the date of filing the Company issued 569,681 shares of common stock with a value of $14,686 for the conversion of convertible debt.

 

During the period from May 1 to the date of filing the Company issued 115,955 shares of common stock with a value of $3,188 for the conversion of three series D convertible preferred shares.

 

During the period from May 1 to the date of filing the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

 

The Company has evaluated subsequent events to determine events occurring after April 30, 2023 through the date of this report that would have a material impact on the Company’s financial results or require disclosure and have determined none exist.

v3.23.2
Note 1 - Nature of Operations and Continuation of Business: Going Concern (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Going Concern

Going Concern

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern.  Through April 30, 2023, the Company had no revenue, has accumulated deficit of $16,527,130 and a working capital deficit of $1,919,650 and expects to incur further losses in the development of its business, all of which cast substantial doubt about the Company’s ability to continue as a going concern.  Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2023 by issuing debt and equity securities and by the continued support of its related parties.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.  There is no assurance that funding will be available to continue the Company’s business operations.

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Basis of Presentation

Basis of Presentation

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States.  The Company’s fiscal year end is April 30.  

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by

removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas.  The ASU is effective for annual and interim periods beginning after December 31, 2021 and early adoption is permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company has evaluated the impact that this new guidance will have on its financial statements and concluded there will be no change.

 

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or results of operations.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Consolidation and Non-Controlling Interest (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Consolidation and Non-Controlling Interest

Consolidation and Non-Controlling Interest

 

These consolidated financial statements include the accounts of the Company, and its wholly owned subsidiary, Long Canyon, through January 15, 2017, and its majority-owned subsidiary, PSSI, from its formation on January 15, 2017.  All inter-company transactions and balances have been eliminated.

 

The non-controlling interest in PSSI, representing 10,883 common shares, or 23.72%, was acquired by several individuals and entities, including related parties, in exchange for services valued at $6,100 and the extinguishment of Company accounts payable – related parties with a book value of $9,835.

 

Reclassification

 

The Company is reclassing the equity section of the consolidated balance sheet for the year ended April 30, 2022, due to a reclassification of series D preferred from mezzanine equity to equity. Initially, the 600 shares of series D preferred were presented in mezzanine equity. The reclassification reduces the mezzanine equity from 600,000 to zero and increase paid in capital to 600,000. Although the series D preferred were in the settlement of convertible notes, and the convertible into common stock, the conversion feature is not set and at the election of the board of directors. The Company also reclassed series A preferred shares increasing the preferred A shares by 59 reducing paid in capital by the same amount. The impact of the reclassification effect only balance sheet presented as of April 30, 2022.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Impairment of Inventory (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Impairment of Inventory

Impairment of Inventory

 

The Company reviews the carrying value of its assets annually or whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the asset. The Company determined although their inventory is salable, none has been sold for over 2 years, but there is a potential of obsolescence to the asset. This could occur due to refinement of the finished product or enhancement of the parts used in the product.  The Company has determined that some impairment has occurred and is reserving an impairment. As of April 30, 2023, the Company reserved $40,586 as an impairment of the value of the inventory.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Basic and Diluted Net Loss Per Share (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Basic and Diluted Net Loss Per Share

Basic and Diluted Net Loss per Share

 

The Company computes net loss per share in accordance with ASC 260, Earnings per Share, which requires presentation of both basic and diluted loss per share (“EPS”) on the face of the statement of operations.  Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted

average number of common shares outstanding (denominator) during the period.  Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, convertible preferred stock, and convertible debt, using the if-converted method.  In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all potentially dilutive common shares if their effect is antidilutive.  

 

As of April 30, 2023, convertible debt and related accrued interest payable plus conversion of A, B and D preferred shares are convertible into 48,924,638 shares of the Company’s common stock.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Income Taxes (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes.  The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse.  The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Use of Estimates (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.  The actual results experienced by the Company may differ materially and adversely from the Company’s estimates.  To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Financial Instruments (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Financial Instruments

Financial Instruments

 

Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value using a hierarchy based on the level of independent, objective evidence when measuring fair value using a hierarch based on the level of independent, objective evidence surrounding the inputs used to measure fair value.  A financial instrument’s categorization with the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy prioritized the inputs into three levels that may be used to measure fair value:

 

Level 1:  applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

 

Level 2:  applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in markets that are not active.

 

Level 3:  applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

 

As of April 30, 2023 and 2022, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.

 

Liabilities measured at fair value on a recurring basis were estimated as follows at April 30, 2023 and 2022:

 

Total

Level 1

Level 2

Level 3

2022

 

 

 

 

Derivative liabilities

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$     305,232

$          --

$          --

 $  305,232

 

 

 

 

 

2023

 

 

 

 

Derivate liabilities

$   65,826

$          --

$          --

$    65,826

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$   65,826

$          --

$          --

$   65,826

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Derivative Liabilities (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Derivative Liabilities

 

Derivative Liabilities

 

We have identified the conversion features of certain of our convertible notes payable as derivatives.  We estimate the fair value of the derivatives using the Black-Scholes pricing model.  We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, and a gain or loss on change in derivative liabilities as applicable.  These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility and variable conversion prices based on market prices as defined in the respective agreements.  These inputs are subject to significant changes from period to period and to management's judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Non-monetary Transactions (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Non-monetary Transactions

Non-Monetary Transactions

 

All issuances of the Company’s common stock for non-cash consideration have been assigned a dollar amount equaling either the market value of the shares issued, or the value of consideration received whichever is more readily determinable.  The majority of the non-cash consideration received pertains to services rendered by consultants and others and has been valued at the market value of the shares issued.

 

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Stock-Based Compensation (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and consultants in accordance with FASB ASC 718. Stock-based compensation to employees is measured at the grant date, based on the fair value of the award, and is recognized as expense over the requisite employee service period. The Company estimates the fair value of stock-based payments using the Black Scholes option-pricing model for common stock options and warrants and the closing price of the Company’s common stock for common share issuances.

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all investments purchased with original maturity of three or fewer months to be cash equivalents.

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Inventory (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Inventory

Inventory

 

Inventories are stated at the lower or cost of market using the first-in; first-out (FIFO) cost method of accounting. The inventory consists of raw materials used to make products, work in progress of zero and finished goods for sale with a total value of inventory after impairment of $34,512.

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Equipment (Policies)
12 Months Ended
Apr. 30, 2023
Policies  
Equipment

Equipment

 

Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets which is 36 months. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.

v3.23.2
Note 2 - Summary of Significant Accounting Policies: Financial Instruments: Fair Value, Assets Measured on Recurring Basis (Tables)
12 Months Ended
Apr. 30, 2023
Tables/Schedules  
Fair Value, Assets Measured on Recurring Basis

Total

Level 1

Level 2

Level 3

2022

 

 

 

 

Derivative liabilities

$     305,232

$          --

$          --

$    305,232

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$     305,232

$          --

$          --

 $  305,232

 

 

 

 

 

2023

 

 

 

 

Derivate liabilities

$   65,826

$          --

$          --

$    65,826

 

 

 

 

 

 

 

 

 

 

Total liability measured at fair value

$   65,826

$          --

$          --

$   65,826

v3.23.2
Note 6 - Convertible Debt: Schedule of Derivative Liability Related to the Conversion Feature (Tables)
12 Months Ended
Apr. 30, 2023
Tables/Schedules  
Schedule of Derivative Liability Related to the Conversion Feature

Balance at April 30, 2021

910,511

 

 

Issuance and conversion of convertible debt, net

(113,092)

 

 

Gain on derivative liability

(492,187)

 

 

Balance at April 30, 2022

305,232

 

 

Issuance and conversion of convertible debt, net

(73,900)

 

 

Gain on derivative liability

(165,506)

 

 

Balance at April 30, 2023

  65,826

v3.23.2
Note 6 - Convertible Debt: Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions (Tables)
12 Months Ended
Apr. 30, 2023
Tables/Schedules  
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

 

2023

2022

Risk-free interest rate

4.74%

.25%

Expected life in years

0.10

0.25-0.96

Dividend yield

0%

0%

Expected volatility

318.00%

222.00%

v3.23.2
Note 8 - Warrants and Options: Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Tables)
12 Months Ended
Apr. 30, 2023
Stock Options  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

 

Options and

Warrants

Weighted

Average

Exercise Price

Weighted Average

Remaining

Contract Term

(Years)

Aggregate

Intrinsic

Value

 

 

 

 

 

 

Outstanding and exercisable at April 30, 2021

38,367

 

14.30

2.48

$ 239,861

Granted by adjustment

133,213

 

1.40

2.31

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

(1,580)

 

--

--

--

Exchanged for preferred shares

(200,000)

 

--

--

--

Outstanding and excisable at April 30, 2022

--

 

--

--

--

Exercised

--

 

--

--

--

Forfeited, expired or cancelled

--

 

--

--

--

Outstanding and exercisable at April 30, 2023

--

 

--

--

--

v3.23.2
Note 9 - Income Tax: Schedule of Deferred Tax Assets and Liabilities (Tables)
12 Months Ended
Apr. 30, 2023
Tables/Schedules  
Schedule of Deferred Tax Assets and Liabilities

 

2023

 

2022

 

 

 

 

 

Income/(Loss) Before Income Taxes

$

(2,627,563)

$

(718,325)

Taxable income(loss)

 

(2,462,057)

 

(242,327)

Valuation Allowance

 

 

 

1,069,501

Net Operating Losses

 

(7,554,918)

 

(5,092,861)

Tax Rate

 

21%

 

21%

 

 

 

 

 

Deferred Tax Assets

 

(1,586,533)

 

(1,069,501)

Valuation Allowance

 

1,586,533

 

1,069,501

Net Deferred Tax Assets

$

--

$

--

v3.23.2
Note 9 - Income Tax: Schedule of Effective Income Tax Rate Reconciliation (Tables)
12 Months Ended
Apr. 30, 2023
Tables/Schedules  
Schedule of Effective Income Tax Rate Reconciliation

2023

 

2022

 U.S. federal statutory rate

21%

 

21%

 Net operating loss

(21%)

 

(21%)

Effective tax rate

--%

 

--%

v3.23.2
Note 1 - Nature of Operations and Continuation of Business (Details)
12 Months Ended
Apr. 30, 2023
Details  
Entity Incorporation, State Country Name Delaware
Entity Incorporation, Date of Incorporation May 27, 1998
v3.23.2
Note 1 - Nature of Operations and Continuation of Business: Going Concern (Details) - USD ($)
12 Months Ended 178 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Apr. 30, 2023
Details      
Net gain (loss) attributed to the Company $ 2,575,641 $ 675,624 $ 16,527,130
Working capital deficit $ 1,919,650   $ 1,919,650
v3.23.2
Note 2 - Summary of Significant Accounting Policies: Impairment of Inventory (Details) - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Details    
Impairment of asset $ 40,586 $ 0
v3.23.2
Note 2 - Summary of Significant Accounting Policies: Basic and Diluted Net Loss Per Share (Details)
Apr. 30, 2023
shares
Details  
Convertible debt and related accrued interest payable plus conversion of A, B and D preferred shares convertible into shares of common stoc 48,924,638
v3.23.2
Note 2 - Summary of Significant Accounting Policies: Financial Instruments: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($)
Apr. 30, 2023
Apr. 30, 2022
Fair Value, Inputs, Level 1    
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset $ 0 $ 0
Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral   0
Convertible Promissory Note 0  
Fair Value, Inputs, Level 2    
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset 0 0
Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral   0
Convertible Promissory Note 0  
Fair Value, Inputs, Level 3    
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset 65,826 305,232
Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral   305,232
Convertible Promissory Note 65,826  
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset 65,826 305,232
Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral   $ 305,232
Convertible Promissory Note $ 65,826  
v3.23.2
Note 3 - License Agreement (Details)
12 Months Ended
Apr. 30, 2023
USD ($)
Impairment, Long-Lived Asset, Held-for-Use $ 378,600
Initial License Fee  
Intangible Assets, Current 25,000
License Agreement  
Intangible Assets, Current $ 353,600
v3.23.2
Note 4 - Related Party Transactions and Balances (Details) - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Notes payable- related party $ 115,600 $ 0
Loan agreement 19,050  
Preferred shares issued to related parties 1,074,250  
Accounts Payable, Related Parties, Current $ 910,524 $ 1,554,639
Preferred Stock    
Preferred shares issued to related parties 279,026  
Preferred shares issued to related parties $ 28  
v3.23.2
Note 5 - Notes Payable (Details) - USD ($)
3 Months Ended 12 Months Ended
Apr. 30, 2023
Apr. 30, 2023
Apr. 30, 2022
Notes payable $ 64,092 $ 64,092 $ 375,042
Notes Payable, Net 175,692 175,692 375,042
Notes payable- related party 115,600 115,600 0
Loan agreement $ 19,050 $ 19,050  
Preferred Stock      
Preferred shares for notes payable 53,750 53,750  
March 2018 Note Payable      
Notes payable     25,000
July 6, 2018 Note Payable      
Notes payable     250,000
July 18, 2018 Note Payable      
Notes payable     $ 114,226
Notes Payable, Net $ 20,042 $ 20,042  
v3.23.2
Note 6 - Convertible Debt (Details) - USD ($)
3 Months Ended 12 Months Ended
Apr. 30, 2023
Apr. 30, 2023
Apr. 30, 2022
Convertible notes payable, net of discount $ 319,767 $ 319,767 $ 305,127
Gain (loss) on extinguishment of debt   849,329 36,682
Common stock issued for convertible debt   76,711 132,728
Preferred shares for notes payable   322,500  
Convertible Notes Payable $ 305,127 305,127 $ 319,767
Common Stock      
Gain (loss) on extinguishment of debt   $ 0  
Common stock issued for conversion of debt shares   1,023,626 41,551
Preferred shares for notes payable   $ 0  
Preferred Stock      
Gain (loss) on extinguishment of debt   $ 0  
Preferred shares for notes payable 53,750 53,750  
Preferred shares for notes payable   $ 4  
Convertible Note Payable 1      
Convertible notes payable, net of discount $ 17,000 $ 17,000  
Preferred Stock Dividends, Shares   17,000  
Convertible Note Payable 6      
Convertible notes payable, net of discount 20,000 $ 20,000  
Convertible Note Payable 7      
Convertible notes payable, net of discount 25,000 25,000  
Convertible Note Payable 14      
Convertible notes payable, net of discount 330,626 330,626  
Convertible Note Payable 26      
Convertible notes payable, net of discount $ 220,000 $ 220,000  
v3.23.2
Note 6 - Convertible Debt: Schedule of Derivative Liability Related to the Conversion Feature (Details) - Derivative Liability - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Apr. 30, 2021
Derivative Liability $ 65,826 $ 305,232 $ 910,511
Issuance and conversion of convertible debt- net (73,900) (113,092)  
Gain on Derivative Liability Related to the Conversion Feature $ (165,506) $ (492,187)  
v3.23.2
Note 6 - Convertible Debt: Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions (Details)
12 Months Ended
Apr. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 4.74%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term 1 month 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 318.00%
v3.23.2
Note 7 - Equity (Details) - USD ($)
3 Months Ended 12 Months Ended
May 20, 2019
Apr. 30, 2023
Apr. 30, 2023
Apr. 30, 2022
Apr. 09, 2023
Preferred Stock, Shares Authorized   20,000,000 20,000,000    
Preferred Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001    
Series A Preferred Shares Cancelled         657,895
Series B Preferred Shares Issued to replace cancelled shares         657,895
Preferred shares issued to related parties     $ 1,074,250    
Preferred shares for notes payable     322,500    
Loss on stock issuance     849,329 $ 65,007  
Shares issued for service     $ 294,998 $ 0  
Stockholders' Equity, Reverse Stock Split     During the year ended April 30, 2022 the Company completed a reverse split of one share for each 500 shares. The presentation of the common shares are retroactive in the number of shares outstanding for both 2022 and 2021. The reverse resulted in a decrease in common stock and an increase in paid in capital    
Series A Preferred Stock          
Preferred Stock, Shares Authorized   20,000,000 20,000,000 20,000,000  
Preferred Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001 $ 0.0001  
Preferred Stock, Shares Issued   2,925,369 2,925,369 3,583,264  
Preferred Stock, Shares Outstanding   2,925,369 2,925,369 3,583,264  
Series B Preferred Stock          
Preferred Stock, Shares Authorized   20,000,000 20,000,000 20,000,000  
Preferred Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001 $ 0.0001  
Preferred Stock, Shares Issued   1,913,655 1,913,655 520,000  
Preferred Stock, Shares Outstanding   1,913,655 1,913,655 520,000  
Series D Preferred Stock          
Preferred Stock, Shares Issued   592 592    
Preferred Stock, Shares Outstanding   592 592    
Preferred Stock          
Preferred shares issued to related parties     279,026    
Preferred shares issued to related parties     $ 28    
Preferred shares for notes payable   53,750 53,750    
Preferred shares for notes payable     $ 4    
Preferred shares issued for accrued expense     399,219    
Preferred shares issued for accrued expense     $ 39    
Shares issued for service     25,000    
Shares issued for service     $ 2    
Additional Paid-in Capital          
Preferred shares issued for accrued expense     $ 1,505,118    
Common Stock Issuance 8          
Stock Issued During Period, Shares, New Issues 5,663        
Preferred Stock Issuance 1          
Stock Issued During Period, Shares, New Issues 283,135        
Stock Issued During Period, Value, New Issues $ 28        
Preferred Stock Issuance 3          
Stock Issued During Period, Shares, New Issues       456,605  
Stock Issued During Period, Value, New Issues       $ 470,981  
Preferred Stock Issuance 4          
Stock Issued During Period, Shares, New Issues       657,895  
Stock Issued During Period, Value, New Issues       $ 25,000  
Preferred Stock Issuance 5          
Stock Issued During Period, Shares, New Issues     600    
Stock Issued During Period, Value, New Issues     $ 600,000    
Common Stock Issuance 1          
Stock Issued During Period, Shares, New Issues       41,551  
Stock Issued During Period, Value, New Issues       $ 132,728  
Common Stock Issuance 2          
Stock Issued During Period, Shares, New Issues       265,241  
Stock Issued During Period, Value, New Issues       $ 469,579  
Common Stock Issuance 3          
Stock Issued During Period, Shares, New Issues     1,023,626    
Stock Issued During Period, Value, New Issues     $ 76,711    
Common Stock Issuance 4          
Stock Issued During Period, Shares, New Issues     292,119    
Common Stock Issuance 5          
Stock Issued During Period, Shares, New Issues     79,766    
v3.23.2
Note 8 - Warrants and Options: Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - Stock Options
12 Months Ended
Apr. 30, 2023
USD ($)
$ / shares
shares
Apr. 30, 2022
USD ($)
$ / shares
shares
Apr. 30, 2021
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number | shares 0 0 38,367
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares $ 0 $ 0 $ 14.30
Share Based Compensation Arrangement By Share Based Payment Award, Weighted Average Remaining Contract Term (Years) 0 0 2.48
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value | $ $ 0 $ 0 $ 239,861
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures | shares   133,213  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares   $ 1.40  
Share Based Compensation Arrangement By Share Based Payment Award, Grants in Period, Weighted Average Remaining Contract Term (Years)   2.31  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | $ $ 0 $ 0  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares $ 0 $ 0  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period | shares 0 (1,580)  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $ / shares $ 0 $ 0  
Exchanged for Preferred Shares | shares   (200,000)  
v3.23.2
Note 9 - Income Tax: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Apr. 30, 2023
Apr. 30, 2022
Details        
Income/(Loss) Before Income Taxes $ (2,627,563) $ (718,325) $ (2,627,564) $ (718,325)
Taxable income(loss) (2,462,057) (242,327) (2,462,057) (242,327)
Valuation Allowance 1,586,533 1,069,501 1,586,533 1,069,501
Operating Loss Carryforwards $ (7,554,918) $ (5,092,861) $ (7,554,918) $ (5,092,861)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00% 21.00% 21.00% 21.00%
Deferred Tax Assets $ (1,586,533) $ (1,069,501) $ (1,586,533) $ (1,069,501)
Net Deferred Tax Assets $ 0 $ 0 $ 0 $ 0
v3.23.2
Note 9 - Income Tax (Details) - USD ($)
Apr. 30, 2023
Apr. 30, 2022
Details    
Operating Loss Carryforwards $ 7,554,918 $ 5,092,861
v3.23.2
Note 9 - Income Tax: Schedule of Effective Income Tax Rate Reconciliation (Details)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Apr. 30, 2023
Apr. 30, 2022
Details        
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00% 21.00% 21.00% 21.00%
Net operating loss     (21.00%) (21.00%)
Effective Income Tax Rate Reconciliation, Percent     0.00% 0.00%
v3.23.2
Note 10 - Commitments and Contingencies (Details)
12 Months Ended
Apr. 30, 2023
USD ($)
EMAC Handels Ag  
Monthly fee for administration services $ 7,500
Monthly fee for Office Rent 250
Monthly fee for Office Supplies 125
Merrill W Moses  
Monthly fee for administration services 2,500
Monthly Director's fee per Service Agreement 7,500
Charles C Hooper  
Monthly fee for administration services 5,000
RAB Investments  
Monthly fee for administration services 5,000
Monthly fee for Office Rent 250
Monthly fee for telephone $ 125

Defense Technologies (PK) (USOTC:DTII)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Defense Technologies (PK) Charts.
Defense Technologies (PK) (USOTC:DTII)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Defense Technologies (PK) Charts.